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In the past few decades there has been a significant increase in the number of people with type 2 
diabetes (T2D) worldwide. Socioeconomic developments have led to changes in diet, lifestyle, and 
environmental factors, which have been associated with complex changes in disease patterns, evident 
from the increasing prevalence of non-communicable diseases, including T2D. Cumulative evidence 
suggests that long term activation of pro-inflammatory immune responses contribute to the 
development of T2D. This phenomenon has piqued the interest of researchers in the potential of 
targeting inflammation to prevent and/or treat T2D. Despite the strong evidence that T2D is 
associated with an increased risk of infectious diseases, recent evidence suggests that helminths and 
their secreted proteins can modulate the host’s immune system by activating regulatory pathways 
which can control inflammatory immune responses associated with T2D. Moreover, the gut 
microbiota is another substantial player in host metabolism, physiology, nutrition, and immune 
function, and impacts on T2D. On the other hand, helminths have been shown to alter the composition 
of the gut microbiota by promoting species that correlate with good gut health. These helminth-driven 
changes to immunity and microbiota have a major impact on inflammatory metabolic disorders such 
as diabetes.  
This thesis aimed to examine the potential of Nippostrongylus brasiliensis infections and their 
excretory/secretory (ES) proteins as therapeutics in mouse models of T2D, via providing an anti-
inflammatory milieu by normalising gut microbiota composition and restoring/maintaining metabolic 
homeostasis. Firstly, I showed that N. brasiliensis infection is associated with changes in local and 
systemic immune cell populations, and induction of Th2 immune responses measured by IL-4, Rentla 
and Chil3, and might be responsible for the improved glucose metabolism and reduced weight gain 
observed. I next assessed whether administration of N. brasiliensis ES products induces a similar 
phenotype in mice by regulating glucose metabolism. Similar to the results observed with N. 
brasiliensis infection, treatment with adult ES products (AES) or infective third-stage larvae ES 
products (L3ES) from N. brasiliensis improved glucose tolerance and reduced body weight gain in 
mice fed a high glycaemic index (HGI) diet as a model of T2D. In addition, I found for the first time 
that treatment of mice with N. brasiliensis ES was associated with type 2 immune responses measured 
by increased numbers of eosinophils and M2 macrophages and IL-5 in peripheral tissues, and a 
corresponding decrease in the levels of IL-6 in adipose tissue. Thus, helminth infections and their ES 
products are important for suppressing immune responses that drive metabolic dysfunction and T2D.  
Lastly, I investigated for the first time the role of N. brasiliensis infection and their ES products in 
modulation the gut microbiota composition in normal control (NC) mice and in mice fed both high-
fat (HF) and HGI diets to induce T2D. I found modest shifts in species diversity in the intestinal 
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microbial communities of mice with N. brasiliensis infection and mice treated with ES products. 
Infection with N. brasiliensis or treatment with their ES products resulted in non-significant changes 
in a-diversity.	However, infection with N. brasiliensis or treatment with L3ES or AES resulted in 
significant compositional changes in the gut microbiota that occurred at both the phylum and order 
levels. Abundance of the phyla Actinobacteria, Verrucomicrobia, Proteobacteria and TM7, and orders 
Clostridiales, Desulfovibrionales, Burkholderiales, Verrucomicrobiales and Coriobacteriales were 
the most affected by infection or treatment with ES products. Whether these microbial changes are 
essential components in maintenance of glucose metabolism and T2D is yet to be confirmed.  
This project sheds light on the mechanisms by which parasitic helminths and their ES products can 
manipulate their host’s immune and metabolic networks and reveals novel mechanisms by which 
gastrointestinal nematodes and their ES proteins can be harnessed as a source of next generation 
therapeutics for inflammatory and metabolic diseases.    
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Chapter 1- Introduction 
1.1. Diabetes Mellitus 
1.1.1. Definition and Prevalence  
Diabetes mellitus (DM) is a metabolic disorder characterised by chronic hyperglycemia with 
disturbances of carbohydrate, fat, and protein metabolism due to an absence of, or deficiency in, 
insulin secretion, insulin action or both. This condition is associated with long-term dysfunction and 
failure of many organs such as the eyes, kidneys, nerves, heart, and blood vessels (1). DM is divided 
into two main classes. Type 1 diabetes (T1D), also called insulin-dependent diabetes mellitus 
(IDDM), represents around 10% of all cases of diabetes, and is the result of autoimmune destruction 
of beta cells in the pancreas that leads to an absolute deficiency of insulin secretion. Type 2 diabetes 
(T2D) or non-insulin-dependent diabetes mellitus (NIDDM) represents around 90% of all diabetes, 
and is the result of abnormalities in carbohydrate, fat and protein metabolism that results in resistance 
to insulin action on target tissues, leading to a relative deficiency in insulin secretion (1).  
The prevalence of DM is increasing worldwide in both genders, and in all ethnic groups (2). The 
trend of developing diabetes is increasing towards younger people (3). According to International 
Diabetes Federation (IDF), DM is the fourth leading cause of non-communicable disease deaths, and 
is responsible for about 4 million deaths, and accounted for USD 727 billion of the world’s health 
expenditure in 2017 (3). 
IDF estimated that the number of people with all forms of diabetes worldwide will increase from 
424.9 million people in 2017 to 628.6 million people in 2045 (3). There are more people with all 
forms of diabetes living in urban (279.2 million), than in rural (145.7 million) areas, and this gap is 
predicted to widen to 472.6 million people living in urban areas and 156 million people in rural areas 
by 2045 (3). There are however wide variations in prevalence worldwide. The Western Pacific region 
has the highest number of people with all forms of diabetes, with 159 million people, followed by 
South-East Asia (82 million people), Europe (58 million people) and North America (46 million 
people), respectively (Fig.1). The incidence of T1D is increasing, particularly in the age groups under 
20 years, with 1,106,500 cases recorded in 2017 worldwide and approximately 132,600 newly 
diagnosed T1D cases annually (3). T2D occurs in youth, with the highest rates observed in people 
aged 15–19 (4). Moreover, it has been estimated that 352.1 million people have impaired glucose 
tolerance (IGT) worldwide in 2017 (almost half of them under the age of 50), and nearly 212 million 








Figure 1.1. Number of people with all forms of diabetes as determined by the International 
Diabetes Federation, 2017 (3).  
According to the IDF 2017, 425 million people have diabetes mellitus. The majority of cases can be found in 








DM is a multifactorial disease where genetic, environmental, and immunological factors interplay 
in the development of the disease. 
1.1.2.1. Genetics 
	
DM is a multigenic disease. A strong association between family history, and the risk of 
development of diabetes has been documented (5). In addition, family history has been shown to 
affect the phenotype of patients with DM (6). Individuals with first degree relatives who are diabetic 
are at risk of developing diabetes (1). Indeed, the risk of developing T2D increases by 40% if 
individuals have one parent with T2D, and 70% if both parents are affected. Moreover, in 
monozygotic twins the concordance of T2D increases by 70% compared with 20-30% in dizygotic 
twins (5, 7). Similarly, the risk of developing T1D increases by 6% if individuals have one parent 
with T1D and by >30% if both parents are affected. In monozygotic twins the concordance of T1D 
increases by 50% compared with 8% in dizygotic twins (8). Many studies have focused on the 
analysis of the genetic factors associated with DM, and over 60 genes have been shown to be 
associated with this disease. The human leukocyte antigen HLA class II region on chromosome 6p21 
is the primary region that contributes to approximately 40–50% of the heritable risk for T1D (9). In 
addition, the insulin gene on chromosome 11p15, the cytotoxic T-lymphocyte-associated protein 4 
(CTLA-4) gene on chromosome 2q33, a protein tyrosine phosphatase non-receptor type 22 (PTPN22), 
the gene on chromosome 1p13 and the interleukin 2 receptor alpha (IL2RA) gene on chromosome 
10p15 have also been found to be associated with T1D (8, 9). Genome-wide association studies have 
identified a number of genetic loci on chromosomes 3q, 4q, 7q, 9q, 10q, 11q 13q, 15q and 17q that 
contribute to the susceptibility to T2D. In European and Asian populations, 45 and 29 loci were 
identified respectively (10). The Transcription Factor 7-like (TCF7L2) gene is the most susceptible 
gene found to be associated with T2D (11). Moreover, genes like Potassium Channel, Inwardly 
Rectifying Subfamily J, Member 11 (KCNJ11) and peroxisome proliferator-activated receptors 
(PPAR𝛾) which are targets for anti-diabetic medications have been shown to affect insulin sensitivity 
(5). Insulin Receptor Substrate 1 (IRS1) and Insulin-like growth factor 1 (IGF1) genes are associated 
with fasting insulin and homeostatic model assessment for insulin resistance (HOMA-IR), and 
deletion of these genes results in insulin resistance (IR) (11). Furthermore, proteins like CDK5 
Regulatory Subunit Associated Protein 1-Like 1 (CDKAL1), cyclin-dependent kinase inhibitor 2A 




1.1.2.2. Environmental factors 
1.1.2.2.1. Lifestyle factors 
	
Several environmental factors influence the development of DM. Lifestyle factors, such as 
obesity, dietary patterns (western diet), and sedentary lifestyle have been found to associate with 
increased incidence of T2D (13). Accumulating evidence suggests that obesity is associated with 
increased risk of metabolic and cardiovascular diseases (14). Excessive caloric intake, in particular 
higher consumption of trans-fats and sugars, causes increased body weight and central adiposity, 
which have a significant impact on T2D (15). High intake of saturated and trans fats, refined cereals 
and sweetened beverages leads to rapid increases in blood glucose levels, which is accompanied by 
an increase in the level of insulin. Overproduction of insulin for long periods of time leads to the 
release of free radicals from pancreatic β-cells, causing deficiency in insulin secretion (15). Similarly, 
accumulation of lipids in the liver and adipose tissue (AT), releases free fatty acids that have a 
deleterious effect on the insulin signaling pathway, leading to IR (13). On the other hand, increased 
fibre, fruit, and vegetable consumption and physical activity, and reduced intake of fat and sweetened 
beverages can reduce body fat mass, improve lipid metabolism, and increase glucose uptake in muscle 
(13), all of which have a positive effect on reducing the risk of developing T2D (16).  
1.1.2.3. Inflammation 
	
Antigen presenting cells (APCs) such as macrophages (MACs), dendritic cells (DCs), antigen-
presenting B-cells, Kupffer cells in liver, adipocytes, and intestinal epithelial cells (IECs) are the main 
components of the innate immune system that detect environmental threats (eg. chemicals and 
pathogens). These threatening materials interact with the pattern recognition receptors such as toll-
like receptors (TLRs), nod-like receptors (NLRs) on or inside these cells leading to activation of 
signaling pathways that induce inflammatory responses (17). Accumulating evidence suggests that 
inflammation and induction of innate immunity are associated with T1D and T2D (18).  
Pro-inflammatory cytokines such as interleukin-1 beta (IL-1β), tumor necrosis factor-α (TNF-α), 
interleukin-6 (IL-6) and chemokines such as Monocyte Chemoattractant Protein-1 (MCP-1) play 
crucial roles in the destruction of pancreatic β-cells (19).  
In T1D, Glutamic Acid Decarboxylase (GAD)-65, tyrosine-phosphate like protein IA-2 (islet 
antibody), and insulin autoantibody (IAA) are the common auto-antigens that mediate destruction of 
pancreatic β-cells (20). MACs and DCs that reside in the pancreatic islets can activate CD4+ and 
CD8+ T cells, leading to the infiltration of more immune cells into islets. This in turn, activates 
autoimmune processes, and induction of β-cell destruction (21). During this process, cytokines such 
as IL-1β, interferon-gamma (IFN-γ), TNF-α and MCP-1 are secreted (20). 
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MAC polarization has been shown to have a key role in systemic insulin resistance, glucose 
tolerance and the development of metabolic disorders, and T2D (22, 23). MACs can differentiate into 
two major effector cells: M1 (pro-inflammatory), and M2 (anti-inflammatory) (24). Activation of M1 
MACs, or classically activated macrophages, requires two signals: firstly, IFN-γ through the IFN-γ 
receptor, and secondly, TNF-α associated with production of IL-1 β, IL-6 and additional TNF-α (25, 
26). On the other hand, activation of M2 MACs, or alternatively activated macrophages requires 
interaction with Th2 cytokines such as interleukin-4 (IL-4), interleukin-13 (IL-13), interleukin-10 
(IL-10), transforming growth factor-beta (TGF-β) and galectin-3 (26).   
Obesity is the main cause of insulin resistance and plays a key role in T2D (23). Liver, AT, and 
muscle are the major players in maintaining glucose homeostasis. Liver maintains glucose 
homeostasis between meals via two processes: glycogenolysis and gluconeogenesis. However, AT 
may regulate glucose homeostasis after a meal indirectly by regulating lipid homeostasis (27). 
Accumulation of lipid in AT, releases free fatty acids (FFAs) that induce the production of adipokines 
such as leptin and the activation of pro-inflammatory cytokines such as IL-1 β, IL-6 and TNF-α. M1 
MACs are also recruited into AT, inducing the secretion of pro-inflammatory cytokines (28). On the 
other hand, resident M2 MACs are responsible for maintaining tissue homeostasis in metabolic 
organs (AT, pancreas, liver, and skeletal muscles) (29). Obesity induces local inflammation and 
recruitment of M1 MACs, leading to an imbalance between M1/M2 MACs and causing impaired 
glucose tolerance in adipocytes, hepatocytes, and myocytes (23, 30). M1 MAC numbers were found 
to be elevated in the islets of humans with T2D, and in a mouse model of T2D. However, in normal 
conditions the islets exhibited large numbers of resident M2 MACs (25, 31). Moreover, the M2 MACs 
comprise 10% of total cells in lean white adipose tissue (WAT) and are associated with the 
maintenance of insulin sensitivity (32).  
Eosinophils play important roles in the induction of Th2 immunity via production of many Th2 
cytokines such as, IL-4, IL-10, IL-13, and TGF-β that participate in anti-inflammatory immune 
responses (27). In a human study, it was found that elevated eosinophil numbers were associated with 
a decreased risk of T2D (33). Interestingly, it has been demonstrated that eosinophils might play an 
important role in the polarisation of MACs towards the M2 phenotype, which in turn allows 
maintenance of metabolic homeostasis, and glucose tolerance (34, 35). In particular, Wu and 
colleagues have highlighted the role of residential eosinophils in AT as a major IL-4-expressing cell 
type that might sustain production of M2 MACs (36, 37). Eosinophil numbers correlated inversely 
with body mass in mice on a high fat diet (HFD). Obesity was associated with decreased AT 
eosinophil numbers, and increased eosinophil expression in IL-5 transgenic mice improved obesity-
induced insulin resistance (37). Interestingly, distinct groups of innate lymphoid cells (ILCs), a 
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recently discovered innate immune cell type, have been shown to be involved in regulating obesity 
(38). Group 2 innate lymphoid cells (ILC2s) are considered as anti-obese immune regulators, and 
they are involved in the browning of AT that induce the lean phenotype. These cells participate in the 
anti-inflammatory immune response deriving the secretion of Th2 cytokines IL-4, IL-5, and IL-13, 
the accumulation of eosinophils in AT, and the polarisation of MACs into the M2 phenotype (38, 39). 
On the other hand, group 1 innate lymphoid cells (ILC1s) have been found to participate in tissue 
inflammation via induction of IFN-γ, and TNF-α, which drives the polarisation of MACs into the M1 
phenotype, in the obese state (38). Administration of the alarmin IL-33 was shown to reduce adiposity 
and fasting blood glucose (FBG), and to improve glucose and insulin tolerance (40). Signaling via 
IL-33 was required for ILC2-induced IL-5 production for induction of visceral adipose tissue (VAT) 
eosinophils, and polarization of VAT MACs towards an M2 phenotype (39-41).  
Figure 1.2 Changes in the environment of resident immune cells in adipose tissue as a result of 
obesity (31).  
Resident immune cells of lean individuals provide an anti-inflammatory milieu to maintain glucose 
homeostasis, however adiposity induces pro-inflammatory immune responses that are an important trigger of 
insulin resistance.   
     Recently, new subpopulations of CD4+ T cells such as T helper 17 (Th17) and T helper 22 (Th22) 
cells have been associated with the pathogenesis of T1D. Interleukin-23 (IL-23), which is mainly 
secreted by MACs, is responsible for the expansion of Th17 cells and is considered to be one of the 
most important cell populations involved in the development of T1D (28). CD4+ T cells skewed 
toward a Th17/Th22 phenotype in AT of obese subjects with insulin resistance and had a greater 
percentage of AT cells producing IL-17 and IL-22 (42). However, IL-22 was found to protect 
endothelial cells from glucose, and lysophosphatidylcholine-induced injury. Blocking the IL-22 
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receptor-1 (IL-22R1) diminished the protective role of IL-22, suggesting a double function of IL-22 
in T2D (43). Moreover, mice deficient in IL-22R1 were prone to develop metabolic disorders when 
fed a HFD. Administration of IL-22 to genetically obese leptin receptor deficient mice (db/db) or HF 
mice had beneficial effects in improving insulin sensitivity, and regulating lipid metabolism in liver 
and AT (44). Many studies have revealed that CD4+ CD25+ Foxp3+ regulatory T cells (Tregs) 
producing IL-10, IL-4 and IL-13 are involved in the suppression of pro-inflammatory Th1/17 
responses (45). In addition, the prospective role of Treg cells in the pathogenesis and treatment of 
T1D and T2D has been highlighted. In a human study, Tregs have been shown to induce M2 MACs, 
maintaining tissue homeostasis (45). Furthermore, in non-obese diabetic (NOD) mice, T1D 
progression is associated with a progressive loss of Treg cells in the inflamed islets and treatment of 
mice with interleukin-2 (IL-2), which mediates the induction of CD25, promoted Treg cell survival 
and subsequently prevented the onset of diabetes (46). Moreover, depletion of Treg cells accelerates 
the development of T1D (47). A study by Feuerer and colleagues demonstrated higher numbers of 
CD4+ Foxp3+ Treg cells in the AT of mice fed a normal diet in comparison with those fed a HFD 
(48). Moreover, transferring Tregs from healthy donor mice to db/db mice improved insulin 
sensitivity (22).  
1.1.3. Diagnosis 
Diabetes is diagnosed by a blood glucose test from venous blood. The biochemical tests that are 
considered for diagnosis of diabetes are: FBG, two hours Oral Glucose Tolerance Test (OGTT) and 
Glycosylated Haemoglobin (HbA1c). The FBG test measures the level of glucose in the blood at a 
single time point, usually after overnight fasting for at least eight hours. The diagnostic level of blood 
glucose for diabetes in this test is ≥ 126 mg/dL (7.0 mmol/L). The OGTT test measures the level of 
glucose in the blood at two time points. This test is also performed after overnight fasting. The patient 
is given glucose solution containing the equivalent of 75 g glucose, and the blood glucose is measured 
at baseline (before the glucose load) and two hours after the glucose load. The diagnostic value in 
this test is blood glucose ≥ 200 mg/dL (11.1 mmol/L). The HbA1c test is commonly used to diagnose 
diabetes in individuals with risk factors and measures the average level of blood glucose over a period 
of three months. The diagnostic cut-off point of diabetes in this test is ≥ 6.5% (1). 
 
1.1.4. Treatment 
Diabetes is a complex, chronic illness, and thus, long-term medical care and treatment are 
needed to help control blood sugar levels and prevent disease complications. Nutritional therapy 
includes managing the amount and type of food taken, weight loss and regular exercise (1). Indeed, 
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150 min/week of moderate exercise or 75 min/week of vigorous aerobic physical activity have been 
shown to improve blood glucose control, reduce cardiovascular risk factors by an increase in high 
density lipoprotein (HDL) cholesterol, decrease in triglycerides (TG), and decrease in blood pressure 
(1). Furthermore, regular exercise may prevent the risk of developing T2D in high risk individuals 
(1). However, for many patients, these methods alone are insufficient in managing the disease. Thus, 
pharmacological therapy is also used to manage insulin secretion and blood glucose levels. Patients 
with T1D require lifelong insulin therapy, usually twice or more daily, with doses adjusted on the 
basis of self-monitoring of blood glucose levels (49). Metformin, sulphonylureas, thiazolidinediones, 
and other drugs are the first line therapy for T2D patients (50), however treatment with insulin is 
sometimes needed. Despite the wide use of these medications in the treatment of T2D, and their 
proven efficacy, these medications can have side effects including hypoglycaemia, weight gain, and 
increased low density lipoprotein (LDL) and TG levels (51). 
1.2. The Hygiene hypothesis  
The transition of nations from primarily agricultural to industrial societies has been associated 
with a rapid rise in the incidence of many immune diseases, including inflammatory bowel disease 
(IBD), multiple sclerosis (MS), rheumatoid arthritis (RA), and T1D (52). The hygiene hypothesis, 
formulated by David Strachan in 1989 (53), proposed that changes in human environment such as 
changed dietary habits, a cleaner environment with improved sanitation, vaccination programmes and 
excessive antibiotic use have reduced our exposure to many infectious agents (53), and symbiotic 
microorganisms (including helminths and gut microbiota) that had an evolutionary relationship with 
humans (54). The coevolution of humans and infectious agents established an immunological 
interaction that ensured the development of regulatory pathways to keep inflammation in check, 
thereby reducing inappropriate immune responses, which are considered the key mediators in many 
immune disorders (54). 
At first, the imbalance between Th1 (pro-inflammatory)/Th2 (anti-inflammatory) responses was 
suggested to explain the epidemiology underlying the hygiene hypothesis, whereby reduced exposure 
to microbial products that stimulate Th1 responses resulted in excessive Th2 responses, culminating 
in an increase in the incidence of Th2-mediated allergic diseases (55). However, it soon became 
apparent that this theory of opposing Th1 and Th2 responses was insufficient to explain the increased 
incidence of Th1/Th17 mediated autoimmune diseases in addition to Th2-mediated allergic 
conditions in developed countries (56). 
As the important role of Treg cells in controlling inappropriate inflammation was revealed, the 
importance of pathogen exposure on the subsequent development of a functional regulatory immune 
response became apparent (57). Indeed, the failure of immunoregulatory mechanisms (primarily Treg 
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responses) can lead to increased immunopathology (58). In DM, mutation in Foxp3, a transcription 
factor that plays a crucial role in the development and function of Treg cells is associated with T1D 
(59). Moreover, the depletion of Treg cells leads to the development of various autoimmune diseases, 
such as gastritis, T1D, and IBD (60). Hence, the balance between Tregs, Th1, Th2, and Th17 
responses is essential to prime immunoregulation and provide protection against diseases that result 
from a dysfunctional immune system.  
1.2.1. Studies supporting the hygiene hypothesis 
The biota that inhabits the mammalian body is a major driving force in shaping the mammalian 
immune system (61). The mode of child delivery (Cesarian section) and feeding (formula vs. breast 
feeding), as well as antibiotic therapy, have a strong effect on the early distribution of gut microbiota. 
These, in turn, affect the susceptibility of individuals to many inflammatory diseases and allergic 
disorders (61-63). Helminth parasites are another important element of the human biome, and they 
have co-evolved over millennia, resulting in “pathogen tolerance” through the induction of regulatory 
immune responses (64). Many epidemiological studies have demonstrated the importance of an early 
exposure to different pathogens on the development of the immune system. Absence of early 
exposure to pathogens is thought to increase susceptibility to allergic and autoimmune diseases like, 
asthma, IBD, and T1D (65). This phenomenon is also supported by many studies showing a higher 
incidence of allergic conditions such as asthma (66), atopy (67), and IBD (68) in urban areas 
compared to rural areas. Similarly, other studies have found an increase in the prevalence of allergy 
and MS in the developed world compared to helminth-endemic areas or regions with poor sanitation 
(69, 70). Moreover, studies have found an increase in allergen skin reactivity after anthelmintic 
treatment (71). Birth mode, breast feeding, and antibiotic usage have an effect on the composition of 
gut microbiota and have been associated with the development of DM and other metabolic diseases. 
For instance, babies born via cesarean section harbored bacterial communities dominated by 
Staphylococcus, Corynebacterium, and Propionibacterium spp. However, vaginally delivered babies 
harbored bacterial communities dominated by Lactobacillus, Prevotella, or Sneathia spp. (72). 
Cesarean delivery and short term of breast feeding positively associated with atopic dermatitis (73). 
Moreover, a meta-analysis found a 20% increase in the risk of asthma and T1D in children delivered 
by cesarean section compared to vaginal delivery (74, 75). In a cohort study of 1,650 German school 
children, cesarean delivery resulted in a more than two-fold increase in childhood T1D risk compared 
to vaginal delivery (76). The use of antibiotics early in life has been associated with paediatric IBD 
(77), and increases the risk of asthma in early childhood (78). Moreover, antibiotic exposure during 
the first 6 months of age has been associated with an increase in body mass (63).  
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1.3. Helminth infection 
Nematodes (also known as roundworms), trematodes (also known as flatworms), and cestodes 
(also known as tapeworms) are the three main groups of parasitic helminths (79). The major 
gastrointestinal (GI) nematodes of humans, often referred to as soil-transmitted helminths (STH), are 
the cause of one of the most important neglected tropical diseases, and include the ascarids (eg. 
Ascaris lumbricoides), hookworms (eg. Necator americanus, Ancylostoma sp.), threadworms (eg. 
Strongyloides stercoralis) and whipworms (eg. Trichuris trichiura) (80). Successful parasites employ 
different strategies to maintain a harmonious relationship with their host in order to survive (64). It 
is well established that helminth infections induce a profound Th2 response but without the hallmark 
features of serious allergy such as urticaria or anaphylaxis, and this phenomenon is attributed to the 
ability of helminths to promote regulatory networks that prevent excessive inflammation (81). 
Induction of a Th2 immune response is associated with an increase in the levels of IL-4, IL-5, IL-9, 
IL-13 and IL-21 as well as expansion of specific effector cells, such as eosinophils, MACs, mast cells, 
neutrophils, basophils and ILCs (82). M2 MACs have been shown to play an important role in host 
protective immunity against helminth infections (83). IL-4 and IL-13 induce M2 MACs by signalling 
through the IL-4 receptor alpha/ signal transducer, and activator of transcription 6 (IL-4Rα /STAT6). 
These cells are multi-faceted and orchestrate diverse processes such as immune regulation, tissue 
repair, and worm expulsion and resistance (64, 83). The protective effect of M2 MACs depends on 
the expression of arginase-1 (Arg1), chitinase-like 3 (Ym1) and Resistin-like molecules (RELMα and 
β) (83). Eosinophil numbers are increased in the blood following helminth infection and they are 
rapidly recruited to the site of infection where they participate in worm killing through the secretion 
of toxic mediators such as major basic protein, eosinophil peroxidase and eosinophil neurotoxin, in 
addition to the production of various chemokines, and cytokines such as, IL-4, IL-5, TGF-β (82, 84). 
Moreover, a rapid rise in Foxp3+ Tregs mediated by IL-10 and TGF-β are reported after helminth 
infections. This response plays an instrumental role in regulating inflammation in response to 
helminth infection. Depletion of these cells has an influence on both pathology and resistance to 
infection (reviewed in ref (85)). Generally, the infective stage of STHs enter their host either orally 
or via skin penetration, and mature to become adult worms which inhabit different niches within the 
intestine (86). N. brasiliensis is a GI hookworm-like nematode of rats but has been studied extensively 
in the mouse (87). The lifecycle of this parasite involves two phases; a free-living phase in the external 
environment, and parasitic phase that takes place inside the definitive rodent host. This latter phase 
commences when infective third-stage larvae (L3) penetrate the skin and enter the circulation to reach 
the lung vasculature. In the lungs they moult to (L4), break through the alveoli and are then coughed 
up and swallowed as they enter the digestive system to reach the small intestine. In the small intestine, 
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they moult to L5 then become dioecious adults which mate. The female worm starts releasing eggs 
in the host faeces, which then hatch into L1 then L2 and finally L3 in the soil, before the L3 penetrates 
the tissues of a new host (88). Following GI nematode infections, APCs such as DCs, MACs, 
basophils and ILC2s play different roles in response to infection through influencing the induction of 
both Th2 and Treg immune responses (reviewed in ref (86)). Eosinophils (89), neutrophils, MACs 
(90, 91), and ILCs (92, 93) are essential in maintaining protection against N. brasiliensis infection in 
mice through orchestrating Th2 immune responses (94, 95). Both eosinophils and M2 MACs 
accumulate at sites of N. brasiliensis infection where they participate in worm killing and expulsion, 
and tissue remodelling. Activation of STAT6 by IL-4 and IL-13 play an important role in this process. 
Resistance to N. brasiliensis infection was impaired in eosinophil-deficient mice, and mice lacking 
IL-5 (89, 96, 97), STAT6, IL-4Rα and IL-13 (96). Eosinophils in these mice were recruited (skin, 
lung, small intestine) in very small numbers, more larvae migrated to the lungs, and adult worms 
displayed prolonged production of eggs compared to control mice (89). Rapid upregulation of YM1, 
RELM-α, and Arg1 were found in the lungs of mice infected with N. brasiliensis with increased IL-
4 and IL-13, indicating the role of M2 alveolar MACs in the induction of host immune responses to 
the infection (91, 98). By day 8 post-infection, these cells suppressed inflammation caused by larval 
migration through the pulmonary environment (99).  
1.3.1. Helminths as a therapeutic modality for immune-mediated inflammation 
1.3.1.1. Evidence from human studies  
Epidemiological studies from helminth-endemic areas show an inverse relationship between 
helminth infection and inflammatory diseases. For instance, there is an inverse relationship between 
the frequency of S. stercoralis infection and the incidence of autoimmune liver disease (100). 
Different clinical trials have highlighted the therapeutic roles of helminths in immune mediated 
diseases. To assess the immunosuppressive properties of N. americanus in coeliac disease (CeD), two 
clinical trials have been conducted where CeD patients were infected with low numbers of live N. 
americanus L3. Hookworm infection induced strong systemic and mucosal Th2 (IL-4, IL-5, IL-9 and 
IL-13) and regulatory (IL-10 and TGF- β) cytokines, supressed the production of IFN-γ and IL-17A 
and increased the numbers of CD4+ CD25+ Foxp3+ cells in duodenal biopsy cultures (105). Moreover, 
suppression of mucosal IL-23 and upregulation of IL-22 (which promotes mucous production) of 
hookworm-infected participants with CeD after gluten challenge was observed. In these studies, 
treatment with N. americanus appears to be safe and hookworm-infected mucosa retained a healthy 
appearance (101-105). Most importantly, moderate gluten challenge of hookworm-infected patients 
did not induce any immunopathology in the gut (villous height to crypt depth ratio) and anti-tissue 
transglutaminase levels remained unchanged (105). 
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In two different studies, infection with live N. americanus was safe for crohn’s disease (CD) 
patients, and resulted in a reduced CD activity index score (106). In the second study on seven IBD 
patients (four with active CD and three with UC), administration of eggs of the porcine GI whipworm 
Trichuris suis was shown to be safe and patients showed improvement in the common clinical indices 
of the disease (107). Another study on 29 patients with CD who received T. suis eggs revealed a 
significant reduction in symptoms (108). Furthermore, a randomized, double blind, placebo-
controlled trial including 54 patients with active colitis showed improvement in 43.3% of the patients 
that received T. suis compared with 16.7% that received placebo treatment (109).  
Moreover, in a cohort study, 12 patients with MS infected with different GI nematodes showed 
significantly lower relapse frequency than uninfected patients, accompanied by an increase in IL-10- 
and TGF-β-secreting cells, and a decrease in IL-12- and IFN-γ-producing cells compared with non-
infected patients (110). When these infected patients received anthelmintic treatment, a significant 
decrease in IL-10- and TGF-β-secreting cells, and a significant increase in IFN-γ- and IL-12-
producing cells was observed (110). Also, a clinical trial of 4 MS patients using experimental T. suis 
therapy revealed a downregulation of Th1 responses (particularly IL-2 and IFN-γ) and an increase in 
Th2 associated IL-4 (111). A survey of self-treatment with helminths (T. suis ova, T. trichiura, N. 
americanus and tapeworm Hymenolepis diminuta) revealed that helminth therapy was effective for 
many people in reducing a variety of inflammatory diseases including IBD, allergies, and 
autoimmune diseases (112). All of these trials have revealed the potential use of helminths as 
therapeutic agents in a wide range of inflammatory mediated diseases. You are mostly reporting the 
positive outcomes. There are many papers that show tht it doesn’t work very well too. You might cite 
a few of them to keep the balance. For example, phase 2 trials of TSO in CD and UC failed to meet 
clinical endpoints. See attached review paper of Stephanie’s that is in press at PLoS Path. If I forget 
to send it to you, remind me. 
1.3.1.2. Evidence from animal models 
A variety of helminths and their products have been tested in different mouse strains to assess 
their roles in the prevention of immune mediated diseases. For instance, in a mouse model of asthma, 
infection with N. brasiliensis suppresses the development of allergen-induced airway eosinophilia 
via the production of IL-10. Interestingly, N. brasiliensis infection alone (in the absence of allergen 
challenge) induced airway and blood eosinophilia (113). Restimulating the MLNs and spleen cells of 
infected mice with anti-CD3 and IL-2 led to increased amounts of IL-4, IL-5, IL-10 and IL-13 in 
comparison to uninfected mice. However, when N. brasiliensis infected mice were challenged with 
OVA allergen, a significant decrease in airway eosinophilia was observed, accompanied by reduced 
levels of eotaxin in the broncho-alveolar lavage fluid of these mice in comparison to uninfected mice 
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challenged with OVA. This effect was possibly dependent on IL-10, as the suppressive effect was 
not observed in mice deficient in IL-10 (113). Infection with the GI nematode of mice 
Heligmosomoides polygyrus showed reduction of airway eosinophilia, and neutrophilia after OVA 
challenge. In addition, elevation in Tregs and regulatory B cells (Bregs), and increased expression of 
TGF-β and IL-10 were also detected in MLNs after challenge (114, 115). 
In two different model of arthritis, N. brasiliensis infection suppressed inflammatory arthritis 
through induction of Th2 immune response. The anti-arthritis effect was dependent on the activation 
of the STAT6 pathway by IL-4/IL-13. Eosinophil numbers increased in the joints of infected mice 
and neutrophil numbers decreased. Expression markers of M2 MACs were increased while 
expression markers of M1 MACs decreased in the joints of infected mice (116). In another model of 
arthritis, mice infected with either N. brasiliensis or H. polygyrus also showed reduced arthritis 
severity that was associated with increased levels of IL-4 (117). 
In a mouse model of dinitrobenzene sulfonic acid (DNBS)-induced colitis, infection with the GI 
nematode Trichinella spiralis reduced the severity of colitis. This was accompanied by a significant 
reduction in IL-12 levels and elevated production of IL-4 and IL-13 (118). In addition, H. polygyrus 
infection of Rag IL-10-/- mice was protective in the T cell transfer model of colitis, and was 
accompanied by alterations in mucosal DC function and reduction in the capacity of intestinal T cells 
to produce IFN-γ and IL-17 (119).  
In a mouse model of MS, rats infected with T. spiralis showed reduction in the clinical score of 
the disease, which was associated with increased levels of IL-4 and IL-10 and decreased levels of 
IFN-γ and IL-17 (120). Likewise, mice infected with Trichinella pseudospiralis showed amelioration 
in the clinical score of the disease with reductions in the levels of IL-17, IL-6, IL-1β, IFN-γ and TNF-
α (121). Infection with H. polygyrus also showed beneficial effects on disease severity, which is 
associated with increased levels of IL-10, TGF-β, and IL-6 in the cerebrospinal fluid and in the serum, 
and decreased IL-17A and IL-2 levels in the serum (122).  
1.3.2. Helminths as a therapy for diabetes mellitus 
Recent epidemiological studies in indigenous communities of north-west Australia, Indonesia, 
rural China and India revealed an inverse correlation between helminth infection and T2D (123-126). 
Additionally, infection with S. stercoralis in Australian Aboriginal communities seems to protect 
against the onset of T2D (127). Moreover, there is an inverse relationship between the prevalence of 
lymphatic filariasis and T1D in southern India (128). NOD mice are widely used as a model to study 
human T1D. In this model of DM, Th1 responses drive the development of inflammation. Many 
studies have investigated the protective role of nematodes (T. spiralis, H. polygyrus, and 
Litomosoides sigmodontis (filarial nematode)) in the treatment of T1D in NOD mice. The data show 
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increased levels of IL-4, IL-5, IL-10, Foxp3, IgG1 and IgE; and decreased levels of IFN-γ and IL-12 
as well as a reduction in CD8+ lymphocyte infiltrate in the pancreas (129-132). However, in IL-4 
deficient mice the protection against diabetes does not depend on the Th2 shift, and requires TGF-β 
and IL-10, which suggests that other regulatory mechanisms might be involved in diabetes prevention 
(129, 130). These findings provide evidence that GI nematodes in particular can induce a mixed 
Th2/Treg response that holds potential for treating T1D (133).   
In the context of T2D, diabetic mice infected with H. polygyrus had improved glucose tolerance, 
decreased HOMA-IR and body weight gain with decreased fat accumulation and fatty acid synthase 
gene expression in the liver compared to uninfected diabetic mice (134, 135). The infection also 
increased the expression of uncoupling protein 1 (UCP1), the M2 MAC markers, RELMα, Arg1, and 
Ym1 and resulted in increased levels of IL-4, IL-13, and IL-10 in the small intestine and MLNs (134, 
135). This shift towards a Th2 environment was accompanied by increased expression of GATA3, 
and Foxp3+ and decreased IFN-γ and IL-17 in the MLNs (134). Similarly, in a mouse model of 
obesity, infection with N. brasiliensis resulted in reduced body weight gain, decreased adipose tissue, 
and liver masses with decreased levels of hepatic triglycerides. This was accompanied by improved 
glucose homeostasis and expression of M2 MAC markers Arg1 and Ym1 and Th2 cytokines IL-4 and 
IL-5 in AT and liver (136). Two additional studies showed that N. brasiliensis infection improved 
insulin sensitivity through induction of IL-33, which mediates activation of resident VAT, ILC2 
producing IL-5- and IL-13-dependent accumulation of VAT, and eosinophilia (37, 41). Additionally, 
mice infected with the filarial nematode L. sigmodontis also showed improved glucose tolerance 
which was associated with increased numbers of eosinophils, M2 MACs, and CD4+ T cells in the AT 
(137). C57BL/6 mice fed a HFD and infected with the blood fluke trematode Schistosoma mansoni 
showed an increase in WAT eosinophils, and M2 MACs. This was associated with metabolic 
homeostasis, and improved insulin sensitivity (138). Moreover, in a mouse model of atherosclerosis, 
treatment with Schistosoma eggs reduced total serum cholesterol and triacylglycerol and cholesteryl 
ester lipids in the liver (139).  
1.4.  Helminth-derived products   
Helminths release soluble mediators that interact with host immune cells. These helminth-
derived molecules, referred to as excretory/secretory (ES) products, play important roles in host 
immune modulation and represent the molecular interface between host and parasite. Several 
helminth-derived molecules that interfere with host immune processes have been described (140). 
These molecules include proteases, protease inhibitors, cytokine homologues, anti-oxidants, various 
esterases, proteins of unknown function, and glycans and lipids (140). Numerous schistosome soluble 
egg antigens (SEA) direct DCs to drive Th2 responses in vitro and in vivo (141). For instance, Lacto-
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N-fucopentaose III (LNFPIII) was capable of inducing Th2 immune responses, with decreased levels 
of IFN-γ, and increased levels of IL-4, IL-5 and IL-10 (142). Additionally, recombinant alpha-1 
induces basophils to produce IL-4 (143), and omega-1 induces Th2 responses by driving production 
of IL-4 (144). Likewise, recombinant thioredoxin peroxidase from the liver fluke Fasciola hepatica 
has been shown to induce the recruitment of M2 MACs, which is associated with the induction of 
Arg1, and high levels of IL-10 (145). Parasitic nematode ES products also drive regulatory immune 
responses. One of the best known examples is ES-62, a phosphorylcholine-bearing glycoprotein from 
Acanthocheilonema viteae that promotes the differentiation of DCs and MACs towards an anti-
inflammatory phenotype (146). ES products of T. spiralis have been shown to modulate the function 
of MACs via inhibiting the production of TNF-α and IL-6 (147) and inducing type 2 cytokine 
responses via increased production of IL-4 and IL-10 (148). H. polygyrus ES (HES) products have 
been reported to inhibit T cell proliferation, and HES-exposed DCs can induce differentiation of IL-
10-producing CD4+ Tregs (149). Moreover, hookworms express molecules with immunosuppressive 
properties, including neutrophil inhibitory factor, anticoagulant peptides and protease inhibitors 
(150). ES products of adult N. americanus bind selectively to NK cells and induce IFN-γ production 
in the presence of both IL-2 and IL-12 (151). Proteases secreted by N. americanus have been shown 
to induce type 2 cytokine production by basophils, and this was associated with increased levels of 
IL-4, IL-5 and IL-13 but not IFN-γ (152). Importantly from the perspective of my PhD project, ES 
products of N. brasiliensis (NES) have been shown to stimulate maturation of DCs towards a Th2 
phenotype (153-156).  
Furthermore, helminths were recently described to secrete particles known as extracellular 
vesicles (EVs). These EVs might have a role in parasite-host interaction and modulation of the host 
immune response (157). Researchers have described EVs from F. hepatica (158), Schistosoma spp. 
(159-161), and N. brasiliensis (162, 163), among others (164, 165), and highlighted their roles in 
parasite-host interactions (161), including both suppression of inflammation and enhanced 
inflammatory responses that predispose to cancer (158). For instance, EVs from S. japonicum 
increase numbers of host peripheral monocytes in vivo (166) and skew MACs towards the M1 
phenotype accompanied by increased levels of TNF-α and IL-12 in vitro (167). Internalization of H. 
polygyrus EVs by MACs caused downregulation of Th1 and Th2 responses which was associated 
with suppressed expression of IL-6, TNF, Ym1, RELMα, and expression of the IL-33 receptor subunit 




1.4.1. Helminth-derived products as therapies for immune-mediated inflammation 
Many studies have indicated the therapeutic potential of helminth ES products for treating a 
diverse array of inflammatory conditions. ES products of the hookworm A. caninum (AcES) 
suppressed intestinal pathology in a dextran sulphate sodium (DSS) mouse model of colitis, and was 
associated with the upregulation of Th2/anti-inflammatory cytokines IL-4, IL-5 and IL-10, and 
downregulation of the pro-inflammatory cytokines IL-6, IL-17 and IFN-γ (169, 170). NES of N. 
brasiliensis suppressed asthma by inducing a Th2 immune response that was associated with 
increased IL-4 and IL-5-producing CD4+ T cells that simultaneously inhibited the development of 
OVA-specific allergic responses (171, 172). ES products of adult T. spiralis attenuated the severity 
of DSS colitis in mice, characterised by a significant reduction in IL-17 levels in the colon and MLNs 
(173). Additionally, rats administered with crude T. spiralis larval (L1) ES products exhibited 
improved clinical scores in experimental autoimmune encephalomyelitis (EAE) as a model of human 
MS. This was associated with increased levels of IL-4, IL-10 and TGF-β, and decreased levels of 
IFN-γ and IL-17 with increases in the proportion of CD4+ CD25+ Foxp3+ T cells at the systemic level, 
and in target organs (spleen and spinal cord) (174). In another study, soluble products of both T. suis 
and T. spiralis significantly reduced the clinical signs of experimental EAE in mice (175). 
Administration of EVs from H. polygyrus, and L. sigmodontis reduced eosinophil numbers and IL-5,  
IL-13 and IL-33 levels in bronchoalveolar lavage, expression induced by allergen Alternaria (176). 
In a more recent study, EVs from N. brasiliensis protected against chemically-induced colitis 
inflammation in mice, which was associated with the suppression of pro-inflammatory cytokines such 
as IL-6, IL-1β, IFNγ and IL-17a and increase of the anti-inflammatory cytokine IL-10 in EV-treated 
groups compared to control groups (163). H. diminuta antigen-pulsed DCs were found to be 
protective in di-nitrobenzene sulphonic acid (DNBS)-induced colitis, and required IL-4Rα and the 
capacity to secrete IL-10 (177, 178). However, ES from helminth is very complex and difficult to 
produce in large scale, hence recombinant Es proteins would be better to produce as new therapeutic 
modality. S. mansoni recombinant protein, 28-kDa glutathione S-transferase (P28GST) prevented 
inflammation in the TNBS model of colitis in both mice and rats, characterised by decreased 
expression of pro-inflammatory cytokines and increased expression of Th2 and anti-inflammatory 
cytokines (179). Recently, one of the most abundant AcES proteins, AIP-2, was produced in 
recombinant form and shown to suppress airway inflammation in a mouse model of asthma via 
induction of tolerogenic DCs, and Foxp3+ Tregs (180). Recombinant filarial cystatin was also found 
to suppress allergic airway inflammation via induction of IL-10-producing MACs that inhibited 
eosinophil recruitment, reduced levels of total IgE and downregulated IL-4 production (181). 
Recombinant T. spiralis Ts-specific 53-kDa glycoprotein (TsP53) also protected mice from colitis, 
typified by a reduced mucosal damage and a reduced inflammatory cell infiltration in the colonic 
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mucosa and submucosa (182). A systematic review reported that treatment of mice with multiple 
helminth recombinant proteins including A. viteae ES-62 - and its small molecule analogue SMA-
12b, 11a and PC-  as well as recombinant SJMHE1 from S. japonicum resulted in significant reduction 
in clinical arthritis score. In all of these studies the treatment with these helminth recombinant proteins 
was associated with a significant decrease in the pro-inflammatory cytokines, such as TNF-α, IL-6, 
IL-1β, IFNγ and IL-17, and with a significant increase in IL-10 (183).  
1.4.2. Helminth-derived products as therapeutics for diabetes mellitus 
T1D being an autoimmune inflammatory condition could potentially be treated with helminth 
ES products. ES of F. hepatica liver flukes prevented T1D in NOD mice through induction of Bregs 
and Tregs, and was associated with induction of M2 MACs and increased IL-10 and TGF-β levels 
(184). Schistosome crude SEA also prevented T1D in the same mouse model, inducing Th2 and Treg 
responses which involved induction of DCs and M2 MACs and increased levels of IL-4, IL-10 and 
TGF-β (185). SEA was also protective in an atherosclerosis model of mice. In this model low dose 
exposure to SEA promoted Th2 responses and reduced the levels of total cholesterol and LDL (186). 
Likewise, mice treated with SEA had lower plasma cholesterol levels, mainly LDL and VLDL, which 
had an effect on reducing the size of atherosclerotic plaques. SEA treatment resulted in reduced 
circulating neutrophils and M1 MACs and TNF-α expression, and increases in M2 MACs producing 
IL-10 (187). The LNFPIII glycan found in schistosome SEA (also found in human breast milk) has 
anti-inflammatory properties via induction of IL-10 from DCs and Arg1+ M2 MACs. HFD mice 
treated with LNFPIII had improved insulin sensitivity and reduced liver TG (188). In two different 
studies the researchers found that ES products from L. sigmosoides and S. mansoni increased the 
number of eosinophils and M2 MACs in AT and were able to improve metabolic homeostasis, and 
insulin sensitivity in murine obesity models (137, 138). 
1.5. The microbiota, mucous and inflammation 
The mammalian body is inhabited by a microbial community that is essential for the formation 
and maintenance of a balanced immune system with functioning effector and regulatory capacity 
(60). Mode of birth and feeding, antibiotic use, dietary habits, and helminth infection can all have an 
impact on the composition and diversity of the intestinal microbiota (189-191). The gut microbiota 
plays an important role in host metabolism, physiology, nutrition, and immune function. In order to 
maintain a homeostatic relationship with these microbes, the intestinal immune system has to reduce 
direct contact with resident bacteria, and limit their exposure to immune system components (60). 
The intestine is protected by mucous secreted mostly by goblet cells. Mucous consists of mucins, 
which are glycoproteins that have more than 50% of their mass as O-glycans. The mucin (Muc) family 
includes members Muc1 to Muc12 (192). Defects in the mucous layer allow resident gut bacteria to 
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be in direct contact with the epithelium, leading to induction of inflammatory responses as 
demonstrated by increased permeability and bacterial adherence to the epithelial cell surface in Muc2-
deficient mice (193), and their progression to develop colitis (194). RELMβ upregulates Muc2 
secretion in human goblet-like cells in culture as well as in mouse goblets cells in vivo where it 
reduces the colonic damage in a mouse model of inducible colitis (195). Moreover, germ-free (GF) 
mice showed a dramatic reduction in RELMβ, however, enhanced expression and robust secretion of 
RELMβ were found following colonisation by commensal bacteria (196). Th2 immune-mediated 
responses can activate RELMβ gene transcription in a STAT6-dependent manner (196). Interestingly, 
induction of Th2 cytokines by GI nematode infections induces RELMβ expression by IECs that is 
essential for helminth expulsion (197). IL-4/IL-13–dependent goblet cell hyperplasia drives N. 
brasiliensis expulsion through production of mucous-containing RELMβ that can encapsulate worms 
and inhibit their ability to sense their source of nutrition (198). In this context, IEC may have an 
immunoregulatory function in addition to their role in maintenance of mucosal barrier integrity. 
Paneth cells are also specialised cells in the intestinal epithelium that secrete antimicrobial molecules 
such as regenerating islet-derived protein III (RegIII-β, RegIII-γ), which is capable of killing Gram 
positive bacteria, limiting the microbial penetration of the epithelial surface and preventing them from 
damaging the epithelium. This homeostatic relationship with gut microbes stimulates a highly 




Figure 1.3. The gut microbiota and host immune responses in the steady state (modified from 
(199)).  
Microbiota and their associated molecular patterns such as short chain fatty acids (SCFAs) and LPS induce 
immune cells such as MACs, DCs and Tregs to provide an anti-inflammatory milieu that maintains immune 
homeostasis.  
	
       The resident M2 MACs and DCs in the intestinal lamina propria have developed mechanisms to 
downregulate pro-inflammatory responses (200). Interaction of intestinal DCs with B and T cells 
results in IgA production, preventing gut microbes from penetrating systemic secondary lymphoid 
tissues (60). Intestinal MACs through MyD88 signaling downregulate pro-inflammatory cytokines, 
resulting in wound healing and tolerance to these commensal bacteria (200). Moreover, stimulation 
of resident ILCs in the lamina propria results in production of IL-22, which plays an important role 
in preventing the spread of bacteria to systemic sites (60). IL-22 is required for protection during 
bacterial infection through direct induction of antimicrobial proteins, RegIII-β, and RegIII-γ (201). 






IL-22 enhanced activation of STAT3-mediated enhancement of mucous-associated proteins (Muc1, 
Muc3, Muc13) within colonic epithelial cells, leading to attenuation of local intestinal inflammation 
(202). Th17 cells also contribute to host defence via producing IL-22. Smaller Peyers patches, lymph 
nodes, and spleens of GF mice have an impact on the maturation of the immune system. These mice 
show decreased (or a complete absence) intestinal Th17 cell development, and decreased production 
of mucosal IgA (203). Interestingly, infection with N. brasiliensis increases IL-22, which directly 
increased goblet cell numbers and RELMβ, Muc1, Muc2 and Muc3 production in the small intestine, 
and which was shown to be essential for helminth expulsion (204). It has been shown that IL-33-
indcued IgA production is important for maintaining microbial homeostasis in the intestine and 
confers protection against colitis. However, IL-33 deficient mice exhibit microbial dysbiosis and are 
prone to develop colitis (205). Noteworthy, in N. brasiliensis infection, IL-33 induced ILC2-
producing IL-13.  
In the healthy state, a number of commensals have been found to induce CD4+Foxp3+ Tregs that 
secrete IL-10 and TGF- β (206). However, there is a significant decrease in these cells with a 
reduction in IL-10 levels in GF mice (207). Microbial-associated molecular patterns such as bacterial 
LPS and SCFAs such as, acetate, propionate and butyrate, which are the main end-products of the 
bacterial fermentation of non-digestible dietary fibres, also participate in modulation of host immune 
responses (208). In the homeostatic state, sensing of LPS molecules occurs directly by host protein 
lipid A-binding protein (LBP). LBP binds to LPS forming LBP/LPS complexes which then bind to 
CD14. The latter LPS/LBP/CD14 complex signals through TLR4, leading to downstream 
inflammatory responses (209). SCFAs, apart from their role as a source of energy for IECs, also play 
an important role in the homeostasis of the intestinal epithelium. These bacterial metabolites induce 
a tolerogenic and anti-inflammatory response, and under some conditions they may also induce Th1 
and Th17 responses through activation of the host G-protein- coupled receptors Gpr-41 and -43 (210). 
The immune mechanisms by which they do this involves an increase in the expression of 
antimicrobial peptides and IL-18 (a key cytokine for the repair, and maintenance of epithelium 
homeostasis) by IECs, and regulation of the differentiation and activation of immune cells such as 
neutrophils, DCs, MACs and T lymphocytes which is most likely associated with activation of 
FoxP3+ Tregs cells, and increased production of IL-10 (208). Moreover, depending on the cytokine 
milieu, these metabolites can promote the differentiation of naïve T cells into T cells producing IL-
17 and IFN-γ (208, 210, 211). Thus, the shift in the composition or density of gut microbiota leads to 




1.5.1. Role of microbiota in immune mediated diseases 
There is substantial evidence highlighting the beneficial role of gut microbiota in shaping the 
mammalian immune response. Disturbance of the intestinal microbial community leads to altered 
immune responses that can result in various human inflammatory disorders (212). Firmicutes (Gram 
positive) and Bacteroidetes (Gram negative) represent the largest phyla in the human and mouse 
microbiota, and a shift in the ratio of these phyla has been associated with many disease conditions 
(213). Studies using GF mice have revealed the crucial role of the microbiota in the pathogenesis of 
many immune-mediated diseases.  
A recent study demonstrated that OVA-sensitized GF mice subjected to an OVA aerosol 
challenge showed increased allergic airway inflammation. Recolonisation of these mice with a 
complex specific pathogen free (SPF) microbiota for 3 to 4 weeks protected mice from increased 
allergic airway inflammation. This was associated with a decrease in regulatory DCs and alveolar M2 
MACs and an increase in proallergic basophils in the lung tissue and airways of GF mice compared 
with SPF mice (214). Administration of SCFAs to mice attenuated the severity of allergic airway 
inflammation. This was associated with increased production of DC and MAC precursors in the bone 
marrow with high phagocytic activity, and reduced expression of MHCII that were less effective at 
inducing Th2 effector cells in the lung. Alteration in the ratio of Bacteroidetes to Firmicutes was 
detected in the gut and the lungs of SCFA-treated mice (215). Administration of DSS to GF mice 
caused severe colitis and led to death of mice on day three (216). Mono-colonisation of GF mice with 
Bacteroides fragilis (BF) significantly ameliorated DSS-induced colitis and increased animal survival 
by 40%. BF-DSS mice exhibited decreased production of the pro-inflammatory cytokine TNF-α and 
increased production of the anti-inflammatory cytokine IL-10 (217). Moreover, administration of 
SCFAs (butyrate) ameliorated the development of colitis-mediated induction of functional Tregs in 
the colonic mucosa (218). 
In human studies, differences in the gut flora of healthy infants in comparison with allergic 
infants were observed. Increases in Clostridia and decreases in Bifidobacteria were shown to 
predispose infants to allergy, and early colonisation with B. fragilis at 3 weeks of age is an early 
indicator of possible asthma later in life (219). Moreover, RA patients showed a reduction in the 
abundance of Bacteroides with an increase in the abundance of Prevotella (220), and an increased 
number and community diversity of Lactobacillus spp. compared to controls. These changes may 
also represent the outcome of disease progression (221). Furthermore, IBD has been associated with 
an alteration in the abundance of Firmicutes and Enterobacteriaceae (222). Different studies have 
reported a reduction in Firmicutes including Clostridium, Ruminococcus and Lactobacillus with a 
decrease or increase of Bacteroidetes in UC patients compared with healthy controls (223). However, 
treatment with SCFAs attenuated the severity of UC (224). Moreover, several studies have 
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highlighted the beneficial effect of SCFAs on human health and their role in the attenuation of the 
severity of different inflammatory diseases (225). These studies highlight the important role of the 
microbiota in the aetiology and pathogenesis of inflammatory diseases.  
1.5.2. Role of microbiota in diabetes mellitus 
The connection between gut microbiota and regulation of host homeostasis and inflammation in 
obesity, metabolic syndrome and DM has been demonstrated (226). The intestine is the primary site 
of nutrient absorption in the body, thus, the immune system and commensal microbiota are sensitive 
to changes in diet. The first evidence came from studies on GF mice, and revealed that GF mice 
administered a Western diet (high-fat, high-carbohydrate) were resistant to obesity-associated insulin 
resistance, hepatic steatosis, dyslipidemia, and elevated systemic TNF-α (227). Conventionally raised 
mice have a 40% increase in body fat content compared to GF mice, and when the latter group were 
colonised with microbiota from conventionally raised mice they experienced a 57% increase in total 
body fat, a 2.3-fold increase in hepatic triglycerides and a dramatic increase in IR (226). Changes in 
the composition and number of gut microbiota were observed in HFD mice compared to mice fed a 
normal chow diet. HFD mice had more Firmicutes and a 75% decrease in Lactobacillus, 279% 
increase in Oscillibacter and fewer Bacteroidetes. These changes were associated with weight gain 
and increased expression of TNF-α in the colon, mesenteric fat and liver, and IL-6 in mesenteric fat 
and liver (228). A reduction in Bacteroidetes and an increase in Firmicutes have also been observed 
in genetically obese ob/ob mice (229). Consistent with the animal studies, a study in obese children 
showed an elevation in the Firmicutes to Bacteroidetes ratio compared with lean children (230). 
Notably, several human studies have reported a decrease in the abundance of Bacteroidetes in obese 
individuals (231) but an increase in the abundance of Firmicutes (232). Others have found a decrease 
in the abundance of Bacteroidetes and an increase in the abundance of Actinobacteria, with no 
differences in Firmicutes (232). However, four studies reported reductions in Firmicutes with an 
increase, decrease or no change in Bacteroidetes (233). 
In the context of diabetes, different studies have associated changes in the intestinal microbiota 
with T2D (234, 235). Reduction in the abundance of Firmicutes, and increase in the proportion of 
Bacteroidetes was observed in diabetic patients (236). Increased levels of Lactobacillus spp., and 
decreased levels of Clostridium spp. have also been observed in T2D patients (230). 
Alteration in the composition of gut microbiota has also been observed in T1D patients. Four 
studies with children reported an increase in Bacteroides with T1D, whereas Firmicutes levels were 
higher in healthy children. Furthermore, a large increase in Bacteroides dorei was observed in 
autoimmune-prone children (237). These results suggest a role of gut microbiota dysbiosis in diabetic 
pathology. Different mechanisms have been proposed linking the effect of dysbiosis in the microbiota 
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on glucose metabolism, and their link to diabetes. Changes in the amount or the types of Gram 
positive bacteria (which lack LPS) vs. Gram negative bacteria (contain LPS) led to increases in gut 
permeability and increases in systemic LPS which is a key mediator in the induction of low grade 
chronic inflammation leading to T2D. Changes in the gut microbiota also lead to changes in the 
concentration of SCFAs which have an effect on the regulation of the intestinal hormones glucagon-
like peptide-1 and the anorectic hormone peptide YY, and stimulating fatty acid oxidation and 
inhibiting de novo lipogenesis and lipolysis. The effect of microbial dysbiosis also extends to 
influencing the concentration of bile acids in the liver and circulating branched chain amino acids 
which have been found to play a role in glucose homeostasis (reviewed in (238, 239). 
1.6. Helminth-microbiota interactions 
Both helminths and gut microbiota play a role in the modulation of the host’s immune system 
(240, 241), and helminth presence has been linked with microbiota diversity and composition (242). 
One of the first positive effects of this interaction was observed in a model of T. muris infection where 
the gut microflora was shown to be essential for T. muris eggs to hatch in the gut and establish an 
infection (243). Chronic infection of C57BL/6 mice with T. muris demonstrated a reduction in 
microbial α-diversity and led to decreased diversity and abundance of Bacteroidetes, specifically 
Prevotella and Parabacteroides, and increased abundance of Firmicutes (244). This was associated 
with decreases in IL-10 and Treg cells and increases in IFN-γ, T-bet+ cells and TCR β+ cells (245). 
N. brasiliensis infection reduced the total bacterial load of Firmicutes and increased the total load of 
Bacteroidetes and Actinobacteria in the ileum of infected mice. At a family level increases in the 
abundance of family Lactobacillaceae with decreases in the abundance of Peptostreptococcaceae, 
Clostridiaceae and Turicibacteraceae. This was associated with increased expression of 
antimicrobial peptides, RELMβ, Muc2 and mucins and increased expression of the M2 MAC 
expression markers YM1 and RELMα, and decreased IL-17 expression in the ileum (246). 
Additionally, H. polygyrus infection resulted in a significant increase in the numbers of γ-
Proteobacteria/ Enterobacteriaceae and members of the Bacteroides/Prevotella in the cecum. Higher 
loads of Gram-positive bacteria such as Lactobacillus and Clostridium were detected in the small 
intestine. Alteration in gut microbiota composition was independent of IL-4/IL-13/STAT6 pathway 
as similar increases in the bacterial load were also observed in infected IL-4 KO mice (247), 
particularly an abundance of Lactobacillus species in the duodenum and ileum of infected mice, with 
increases in Foxp3+ cells and IL-17 levels in the MLNs (248, 249). Infection with H. polygyrus altered 
the intestinal bacterial communities, which led to attenuation of allergic airway inflammation in mice 
inoculated with house dust mite (HDM), increased production of SCFAs and decreased eosinophil 
numbers in the airways of the infected group. On the other hand, in antibiotic-treated mice helminth 
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infection did not attenuate the severity of inflammation. Noteworthy, when antibiotic-treated mice 
were cohoused with helminth infected mice they exhibited the same protective effect (250). 
Nucleotide-binding and oligomerization domain containing protein 2 (NOD2)-/- mice showed 
increases in Bacteroides vulgatus, whereas infection with the GI nematodes T. muris or H. polygyrus 
completely inhibited growth of B. vulgatus, and was accompanied by a significant decrease in 
Prevotella and Bacteroides, and significant increases in the Lachnospiraceae family of the order 
Clostridiales. The NOD2−/− infected mice showed increased IL-4 and IL-13 with decreased IFN-γ 
levels. Administration of a mixture of Clostridiales strains or cohousing of the NOD2−/− uninfected 
mice with NOD2−/− infected mice both resulted in reduction in B. vulgatus levels (251). H. polygyrus 
was also found to have a protective effect against respiratory syncytial virus infection in the lung, and 
this was dependent on the presence of the microbiota, as GF mice showed no protective effect against 
viral infection when infected with the helminths. The protective effect was Th2-independent as Rag-
/- and IL-4-/- mice maintained the same effect (252). Colonisation of rats with the tapeworm H. 
diminuta led to a shift in the microbial community. Most of the changes observed within the 
Firmicutes phylum involved an increase in Clostridia and a decrease in Bacilli (253). Moreover, 
infection with H. polygyrus suppresses obesity via increased UCP1 expression in AT and serum 
norepinephrine (NE) concentration. This was associated with an increase in Firmicutes and 
Proteobacteria phyla, and mainly in Bacillus and Escherichia species (254). In another model, 
infection with Strongyloides venezuelensis improved insulin sensitivity in a mouse model of obesity. 
This was associated with an increase in Firmicutes phylum mainly in Lactobacillus spp., and decrease 
in Bacteroidetes phylum with a decrease in circulating LPS, and an increase in M2 MACs in the 
adipose tissue, and circulating IL-10 (255).  
Furthermore, in the collagen-induced arthritis model, administration of ES-62 protects against 
arthritis-dependent modulation of the gut microbiome (256). ES-62 administration normalises the gut 
microbiota communities (mainly Clostridiaceae, Lachnospiraceae and Ruminococcaceae) and 
maintains barrier integrity. This was associated with an increase in splenic IL-10+ B cells and serum 
IL-10 levels and a decrease in serum IL-6 levels. This effect was lost after antibiotic treatment (256).  
In human studies, infection with S. stercoralis has been associated with a shift in the abundance 
of faecal microbiota, in particular Leuconostocaceae, Ruminococcaceae and Paraprevotellaceae, 
which were significantly increased in the infected groups while bacteria belonging to the order 
Turicibacterales were significantly decreased compared to the control groups (257). A significant 
increase in the intestinal microbial species richness of CeD patients was observed following infection 
with N. americanus with a trends towards increased abundance of species within the Bacteroides 
phylum (258-260). Moreover, higher microbial diversity was found in helminth-infected subjects 
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from indigenous communities in Malaysia compared to helminth negative subjects. Additionally, in 
a comparison between Malaysian and New York residents, Firmicutes were more abundant in the 
New York subjects while Cyanobacteria, Actinobacteria, Tenericutes and Proteobacteria were more 
abundant in Malaysian subjects (261).  
This highlights the role of helminth-induced microbiota alterations in triggering host 
immunomodulatory pathways, which contributes to inhibition of inflammation and reduced disease 
severity (189). 
1.7. Hypothesis underpinning this thesis  
Microorganisms, including parasitic worms and gut microbiota, have co-evolved with their hosts 
over millennia. This coevolutionary relationship has established an immunological interaction that is 
essential for the formation and maintenance of a balanced immune system that is associated with 
induction of Th2/regulatory immune responses and suppression of Th1/Th17 inflammatory 
responses. As mentioned previously in this chapter, data from helminth endemic areas have revealed 
negative associations between helminth infection and incidence of many inflammatory and metabolic 
diseases such as IBD, T1D and T2D. In addition, experimental studies from mouse models and human 
trials showed protective effects of helminths and their ES products against different inflammation-
mediated diseases. On the other hand, many inflammatory diseases, and in particular T2D, were found 
to associate with gut microbiota alterations. Moreover, other studies have highlighted the role of 
helminth infections in altering the composition of the gut microbiota. There is therefore a real need 
to uncouple this three-way relationship between helminths, the microbiome and 
inflammatory/metabolic diseases. Induction of Th1 immune responses that increase production of 
pro-inflammatory cytokines and M1 MACs in AT, liver and pancreas have been associated with T2D. 
Helminth infections induce eosinophils, which play a key role in maintaining M2 MACs. I 
hypothesise that induction of Th2 immune responses by N. brasiliensis and its L3 and adult ES 
products, characterised by eosinophilia in particular, will reduce the inflammatory milieu in target 
tissues associated with T2D and improve insulin sensitivity. Therefore, the major aim of this thesis 
is to examine the impact of infection with N. brasiliensis or administration of their ES products on 
the development of T2D. Microbial dysbiosis promotes the accumulation of pro-inflammatory Th1 
and Th17 cells in the small intestine, and increases production of IL-12, IL-17, IFN-γ and TNF-α. 
However, in homeostatic conditions IECs promote Tregs, and increase production of RELMβ, Muc2, 
IL-10 and TGF-β that downregulate Th1/Th17 immune responses. Moreover, induction of Th2 
immune responses, expansion of eosinophils, and M2 MACs in the IECs and increased production of 
Th2/regulatory cytokines such as IL-4, IL-5, IL-13, IL-10, TGF-β, RELMβ and Muc2 are the main 
features of the host immune response to many GI helminth infections. Targeting the gut microbiota 
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to counter obesity and metabolic-related diseases is highly topical. Given that helminth infections 
promote diversity in the composition of the gut microbiota culminating in a phenotype associated 
with good gut health, improved understanding of these interactions is essential to determine if 
helminths and their secreted products are to be considered as a novel therapeutic platform. Thus, I 
hypothesise that helminth infection provides an anti-inflammatory milieu that normalises gut 
microbiota composition and restores/maintains gut homeostasis. Therefore, in the second aim of this 
thesis I will investigate the effects of N. brasiliensis infection and their ES products on the diversity 
of the gut microbiota. In the final aim, I will further explore the interaction between helminths and 
the microbiota by determining whether N. brasiliensis and its ES products confer protection from 
T2D in a manner that is dependent on the alteration of the gut microbiota. Hence, the overall 
hypothesis of this project is that N. brasiliensis and its secreted products restore gut microbial 
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Diabetes is a major health problem and is considered one of the top 10 diseases leading to 
death globally. This disease has been widely associated with systemic and local inflammatory 
responses, and with alterations in the gut microbiota. Microorganisms, including parasitic worms and 
gut microbiota, have co-evolved with their hosts over millennia. This co-evolutionary relationship 
has established an immunological interaction that is essential for the formation and maintenance of a 
balanced immune system, including suppression of excessive inflammation. Herein we have shown 
that infection with the parasitic nematode N. brasiliensis significantly reduced fasting blood glucose, 
oral glucose tolerance and body weight in two different mouse models of T2D. We also found that 
the infection was associated with elevated type 2 immune responses including increased eosinophil 
numbers in the mesenteric lymph nodes, liver and adipose tissues as well as increased expression of 
IL-4 and alternatively activated macrophage marker genes Rentla, and Chil3 in adipose tissue, liver, 
and gut.  
Our findings show that N. brasiliensis infection is associated with changes in local and systemic 
immune cell populations. These changes are associated with a reduction in systemic and local 
inflammation and might be responsible for the improved insulin sensitivity observed, suggesting that 
experimental hookworm infection could be a novel therapeutic approach for preventing T2D.  
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Diabetes is a metabolic disease resulting from the absence of, or deficiency in, insulin 
secretion, insulin action or both, leading to an abnormal metabolism of carbohydrates and elevated 
levels of glucose in the blood (3). The main types of diabetes are T1D, which represents around 10% 
of all diabetes cases, and T2D, which represents around 90% of all diabetes forms. Diabetes is a fast-
growing health problem worldwide. According to the International Diabetes Federation there were 
424.9 million people living with diabetes with a further 352.1 million with impaired glucose tolerance 
in 2017 (3). Diabetes caused 4 million deaths and accounted for 10.7% of global all-cause mortality, 
and cost USD 727 billion in healthcare spending in 2017 alone (3). 
Cumulative evidence suggests that T2D is associated with inflammation. Induction of Th1 
immune responses, in particular activation of M1 MACs and increased production of pro-
inflammatory cytokines such as IL-1β, IFN-γ, TNF-α and IL-6 play a crucial role in the destruction 
of pancreatic β-cells, and insulin resistance in AT, liver and muscle (17). In contrast, cells such as 
ILC2s, eosinophils, and M2 MACs, as well as increased levels of Th2 cytokines such as IL-5, IL-4, 
and IL-13 have been found to regulate adipose tissue homeostasis (262, 263), liver regeneration (264), 
and gastrointestinal homeostasis (265), leading to whole body metabolic homeostasis.  
Environmental changes such as changes in dietary habits, improved sanitation, vaccination and 
excessive use of antibiotics has reduced our exposure to various infectious agents and symbiotic 
microorganisms (including helminths and gut microbiota) that had a co-evolutionary relationship 
with humans (266). This relationship has established an immunological interaction with highly 
developed regulatory pathways that serve to dampen inappropriate immune responses, which are 
considered the key drivers in many immune-mediated disorders including T2D (267). Helminth 
infections have been found to induce Th2 immune responses by expansion of innate immune cells 
such as eosinophils, M2 MACs, ILCs, and upregulation of cytokines such as IL-4, IL-5 and IL-13. 
Furthermore, it has been widely shown that helminth infections promote expansion and/or 
recruitment of Tregs that play an important role in regulating inflammation (268, 269). Recent 
experimental evidence in animal models has highlighted the therapeutic role of helminth-mediated 
induction of Th2- and Treg-mediated immune responses in many inflammatory diseases such as IBD, 
MS, arthritis, asthma and T1D (270). Likewise, helminth infections also showed promising results in 
patients with IBD, CeD and MS (104, 105, 271). 
In the context of diabetes, epidemiological studies from helminth-endemic areas such as 
Indonesia, rural China, India and Aboriginal communities from North-West Australia found an 
inverse relationship between helminth infection and incidence of T2D (123, 125, 126, 272). 
Additionally, it has been shown that helminth infection of mice with N. brasiliensis, H. polygyrus, L. 
sigmodontis and S. mansoni are associated with significant increases in ILC2s, eosinophils, M2 
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MACs, and Th2 cytokines that result in restoration of glucose levels and improved insulin sensitivity 
in mouse models of obesity (134-137, 262, 263).  
Diabetes has also been found to associate with alterations in the composition of the gut 
microbiota. Human studies as well as studies in animal models of obesity and T2D revealed a shift 
in the abundance of the dominant gut phyla Bacteroidetes and Firmicutes (273-275). Shifts in the 
abundance of these phyla has also been observed after infection with the gastrointestinal nematodes 
N. brasiliensis, T. muris and H. polygyrus (244-247, 276, 277), suggesting that helminth infections 
might have a positive role in maintaining gut homeostasis and preventing the development of T2D 
(255). 
In this study, we found that infection with N. brasiliensis maintains glucose homeostasis, 
probably via induction of Th2 immune responses characterised by increases in eosinophils, M2 MAC 
markers Rentla, and Chil3, and IL-4 levels in lymphoid and non-lymphoid tissues in both high-
glycaemic index (HGI), and high fat (HF) diet-induced T2D. 
2.3. Materials and Methods 
2.3.1. Ethics statement 
All procedures were approved by the JCU Animal Ethics Committee, ethics application 
number A2244. The study protocols were in accordance with the 2007 Australian Code of Practice 
for the Care and Use of Animals for Scientific Purposes and the 2001 Queensland Animal Care and 
Protection Act. 
2.3.2. Animals and diet 
Male C57BL/6 wild-type (WT) (JCU Townsville) mice were used for all experiments (10 
mice per group). At the age of 5 weeks control groups were fed a normal control diet (NC), whereas 
to induce T2D mice were either fed a HGI diet (SF03-30; Speciality Feeds, Western Australia) or a 
HF diet (SF07-066; Speciality Feeds, Western Australia). 
2.3.3. Helminth infection 
N. brasiliensis life cycle was maintained in our laboratory at James Cook University (Cairns). 
Briefly, faeces from N. brasiliensis-infected rats were collected from days 5-9 post-infection. Egg-
containing faeces were mixed with an equal amount of water and charcoal, distributed into Petri dish 
plates and incubated at 26°C. One week after incubation, L3 were collected from the faecal/charcoal 
culture plate, washed three times with PBS, then all infections with N. brasiliensis were performed 
by inoculating subcutaneously 500 third-stage larvae of N. brasiliensis (NbL3) into the skin over the 
interscapular region. To determine if infection with N. brasiliensis could prevent T2D, mice were 
infected once every month with N. brasiliensis starting at 6 weeks of age.  
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2.3.4. Fasting blood glucose (FBG) and oral glucose tolerance test (OGTT) 
The FBG was measured in 6-hour unfed mice. Blood sampling was performed by tail 
bleeding. Mice were screened for blood glucose levels every 2 weeks using Accu-Check® Performa 
(Roche). Mice were considered diabetic when glucose levels reached >12.0 mmol/L. For the OGTT, 
after initial blood collection (time 0) in 6-hour unfed mice, mice were administered D-glucose orally 
(2 g/kg body weight) by gavage. Blood sampling was performed by tail bleeding at 15, 30, 60, 90, 
and 120 minutes after administration of glucose. 
2.3.5. Blood collection for cytokine analyses 
Blood was collected by cardiac puncture for terminal procedures, or submandibular bleeding 
for non-terminal procedures. Serum was separated, collected and stored at -30°C for further analysis. 
2.3.6. Isolation of MLNs, AT and liver 
In brief, epididymal fat pads or liver from male mice fed with ND, HGI or HF diet were 
removed and minced into small pieces. Minced tissues were then transferred to a 50 ml conical tube 
containing 1 ml DPBS (0.5% BSA) (Sigma) and 3 ml collagenase type II (Life technologies), and 
incubated in a rotating shaker (200 rpm) at 37°C for 35 minutes The homogenates were filtered 
through a 70 μm strainer into a new tube and centrifuged at 500 g for 10 minutes at 4°C. Following 
centrifugation, the supernatant was discarded and the pellet was resuspended in 1× red blood cell 
lysis buffer (Sigma) followed by a washing step with 5 ml FACS buffer, and a final centrifugation at 
500 g for 10 minutes at 4°C. 
MLNs were collected and transferred to a 5 ml tube containing 1 ml of RPMI media (Gibco), 
then filtered through a 70 μm strainer.  
Cell viability was assessed by Trypan Blue and cells were blocked using FcR blocking reagent 
(BD biosciences) for FACS analysis.  
2.3.7. Flow cytometry  
Cell surface marker analysis was performed using flow cytometry. Single-cell suspensions 
prepared from MLNs, AT and liver were collected from mice at the times indicated. Cell surface 
markers were stained for 30 minutes at 4°C with rat anti-mouse CD3/CD19-CF594 (Clone:145-
2C11,1D3) F4/80-APC (Clone: T45-2342), CD11c-FITC (Clone: HL3), CD301-pecy7 (Clone: 
LOM-14), CD64-PerCp-Cy5.5 (Clone: X45-5/7.1), CD11b-BV650 (Clone: M1/70), Ly6G-efluor700 
(Clone: 1A8) and Siglec-F-PE (Clone: E50-2440) (BD Bioscience). All antibody incubations were 
performed at 4°C for 30 minutes (isotype controls were included). Data were acquired using a BD 
FACS Aria and analysed using FlowJo software (Tree Star, Inc). 
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2.3.8. Quantitative real-time PCR 
A small piece (<0.5 cm) of AT, liver and small intestine (SI) was collected in a 2 ml Eppendorf 
tube containing 1 ml TRIzol-reagent (Sigma) and homogenised using a TissueLyzer (QIAGEN). 
Tissues were homogenised and RNA was extracted using TRIzol-reagent (Sigma) following the 
manufacturer’s protocol. RNA samples were reverse transcribed to cDNA as follows. After RNA 
quantification, 50-70 ng of each sample was transferred to a 0.2 ml tube and 1 μl of each of oligo(dT) 
(Qiagen) and 10 mM dNTPs were added, followed by incubation at 65°C for 5 minutes in a Veriti 
96-well thermal cycler (Applied Biosystems) followed by incubation on ice for 2 minutes. Four (4) 
μl of first strand buffer (Qiagen), 1 μl of each of 0.1 M DTT (Qiagen), RNAse out and 0.5 μl of 
Superscript III were added to the sample (Qiagen). The sample was incubated for 60 minutes at 55°C, 
then 15 minutes at 70°C. Finally, cDNA was quantified on a Nanodrop 2000 (Thermo scientific).  
For qPCR reactions, 100 ng of RNA was mixed with 12.5 μl of SYBR Green and 2.5 μl of 
each primer of the selected genes in a total volume of 25 μl per sample. A Rotor-Gene Q (QIAGEN) 
was used for real time thermal cycling. All genes were normalised for levels of transcription relative 
to the housekeeping gene β-actin.  
2.3.9. Data analysis 
Data were tested for statistical significance using GraphPad Prism software (version 6). A 
Mann-Whitney U test was applied to test statistically significant differences between two unpaired 
groups with non-parametric distribution. Data that were normally distributed were tested for 
statistical significance using the unpaired t test for comparisons of two groups or the ANOVA test 
followed by the Holm-Sidack multiple-comparison test to compare more than two groups. Values of 
p < 0.05 were considered statistically significant. Results are expressed as mean with SEM or means 
± SD. *p < 0.05; **p < 0.01. 
 
2.4. Results 
2.4.1. Infection with N. brasiliensis maintained glucose homeostasis  
In order to address the prophylactic and therapeutic effect of infection with N. brasiliensis on 
the outcome of T2D, we used two different models of diet (HGI and HF) to induce T2D in C57BL/6 
mice. At week 5 of age, male C57BL/6 mice were divided into groups fed on a NC diet, HGI diet or 
HF diet for up to 30 weeks to induce T2D. To ascertain the prophylactic effect of the infection on 
T2D, mice were infected at week 6 and re-infected once every month until the end of the experiment. 
To ascertain the therapeutic effect, infection with N. brasiliensis started at week 24, and continued 
once every 3 weeks for a total of three infections.  
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As predicted, mice on either HGI or HF diet had a significant increase in the level of FBG 
compared to those on NC (Fig. 2.4.1A and B). Prophylactic infection as well as therapeutic infection 
with N. brasiliensis significantly decreased the FBG levels in all groups, compared to their respective 
uninfected groups (Fig. 2.4.1A and B). A similar result was also observed for the OGTT test. HGI 
and HF diet infected mice had significantly lower levels of blood glucose than the respective control 
(uninfected) groups at all time points, both prophylactically and therapeutically (Fig. 2.4.1 C-F). Of 
note, the blood glucose level of the HGI and HF diet infected groups was also comparable to those 













































































































































































Fig 2.4.1. Infection with N. brasiliensis maintained glucose homeostasis. 
C57/BL6 mice were fed NC or either HGI or HF diets and frequently infected with 500 Nippostrongylus 
brasiliensis L3 larvae. (A) Prophylactic FBG, HGI and HF diets; (B) therapeutic FBG, HGI and HF diets; (C) 
prophylactic OGTT, NC and HGI diets; (D) therapeutic OGTT, NC and HGI diets; (E) prophylactic OGTT, 
NC and HF diets; (F) therapeutic OGTT, NC and HF diets. Statistical significance was determined with 
Student’s t test or Tow-way analysis of variance (ANOVA). Data are expressed as mean ± SEM or as means 




2.4.2. N. brasiliensis infection slowed weight gain in HGI and HF diet models of T2D	
Reduction in the rate of body weight gain was also observed as a result of infection. Mice on 
either HGI or HF diets gained significantly more weight compared to mice on a NC diet (Fig. 2.4.2); 
however, infection with N. brasiliensis significantly reduced the body weight gain in all infected 
groups compared to their uninfected counterparts (Fig. 2.4.2).  
These data indicate that in response to N. brasiliensis infection, HGI and HF diet groups 






























































































Fig 2.4.2. N. brasiliensis infection slowed weight gain in HGI and HF diet models of T2D. 
C57/BL6 mice were fed NC or either HGI or HF diets then frequently infected with 500 Nippostrongylus 
brasiliensis L3 larvae. (A) Prophylactic body weight, NC and HGI diets. (B) Therapeutic Body weight, NC 
and HGI diets. (C) Prophylactic body weight, NC and HF diets. (D) Therapeutic Body weight, NC and HF 
diets. Statistical significance was determined with Tow-way analysis of variance (ANOVA). Data are 




2.4.3. N. brasiliensis infection induces local eosinophilia and Th2 immune responses 
To determine whether an increase in eosinophil numbers could induce a potent Th2 cytokine 
response and alternative activation of MACs in MLNs, AT, liver and gut, mice fed a NC, HGI or HF 
diet were infected with 500 N. brasiliensis L3 and sacrificed at different time points. At the end of 
the experiment MLNs, AT, liver and SI were collected. MLNs, AT and liver tissue were analysed by 
flow cytometry for eosinophils. qPCR analysis was performed on AT, liver and SI to assess M2 MAC 
expression markers. In response to N. brasiliensis infection, there was a significant increase in the 
total number of eosinophils in the MLNs, AT and liver in all groups compared to their uninfected 


























Fig 2.4.3. N. brasiliensis infection induces local and systemic eosinophilia. 
C57/BL6 mice were fed NC, HGI or HF diets and frequently infected with 500 Nippostrongylus brasiliensis 
L3 larvae. (A) Prophylactic eosinophil frequency and total numbers in mLNs, AT and liver; (B) therapeutic 
eosinophil frequency and total numbers in mLNs, AT and liver. Statistical significance was determined with 
Student’s t test. Data are expressed as mean ± SEM and are representative of two different experiments where 

















































































2.4.4. Increased expression of genes involved in Th2 responses in AT, liver and small intestine 
of infected groups 
N. brasiliensis infection significantly upregulated the transcripts for major Th2 cytokines and 
associated proteins, including IL-4, Rentla, and Chil3 in AT, liver (Fig. 2.4.4) and SI (Fig. 2.4.5) of 
all the infected groups compared to their respective naïve groups.  
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Fig 2.4.4. Increased expression of IL-4, Rentla and Chil3 in AT and liver of infected groups. 
C57/BL6 mice were fed NC, HGI or HF diets and frequently infected with 500 Nippostrongylus brasiliensis 
L3 larvae. (A) Prophylactic IL-4, Rentla and Chil3 levels in the AT; (B) prophylactic IL-4, Rentla and Chil3 
levels in the liver; (C) therapeutic IL-4, Rentla and Chil3 levels in the AT; (D) therapeutic IL-4, Rentla and 
Chil3 levels in the liver. Statistical significance was determined with Student’s t test. Data are expressed as 












Diabetes is recognised as the world’s fastest growing chronic condition (3). The number of 
people with T2D is growing all over the world and its health and socioeconomic importance is 
indisputable (3). As mentioned previously, helminth infections have been associated with a lower 
prevalence of T2D, due to their ability to induce type 2 immune responses (123, 125, 126, 272). T2D 
is associated with Th1 and Th17 immune responses, innate immune cells such as M1 MACs and pro-
inflammatory cytokines such as IL-1β, IL-6, IFN-γ, and TNF-α (278). However, in a normal state, 
resident ILCs, eosinophils and Tregs maintain metabolic homeostasis, favoring the production of Th2 
cytokines such as IL-4, IL-5, IL-13, and IL-10 which also drive proliferation of M1 MACs towards 
an M2 MAC-like state (278, 279). 
C57/BL6 mice were fed normal control (NC) diet or either high fat (HF) diet or high glycemic index
(HGI) diet and infected once monthly with 500 L3 N. brasiliensis. (A) Prophylactic IL-4, Rentla and
Chil3 levels in the gut. (B) Therapeutic IL-4, Rentla and Chil3 levels in the AT. Data are expressed
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Fig 2.4.5. Increased expression of IL-4, Rentla and Chil3 in gut of infected groups 
C57/BL6 mice were fed NC, HGI or HF diets and frequently infected with 500 Nippostrongylus brasiliensis 
L3 larvae. (A) Prophylactic IL-4, Rentla and Chil3 levels in the gut; (B) therapeutic IL-4, Rentla and Chil3 
levels in the gut. Statistical significance was determined with Student’s t test. Data are expressed as mean 




N. brasiliensis is a strong inducer of type 2 immunity, involving activation and expansion of 
CD4+ T cells that produce cytokines such as IL‐4, IL‐5, IL‐9, IL‐10, and IL‐13. This response induces 
a systemic and localised eosinophilia and activates ILC2 and M2 MACs, which play an important 
role in generating protective immunity against N. brasiliensis (89, 280-285). We therefore set out to 
investigate the role of helminth-induced type 2 immunity, and the mechanisms underlying protection 
against the development of T2D-induced insulin resistance. C57BL/6 mice were fed a HGI or HF 
diet and infected frequently with N. brasiliensis. This strain of mice is genetically susceptible to 
obesity, glucose intolerance, hyperglycaemia and T2D when fed a HF or HGI diet (286, 287). Here, 
we demonstrate that infection with N. brasiliensis had a beneficial effect, both prophylactically and 
therapeutically against T2D in two different diabetic diets. Our findings are consistent with a role for 
helminth infection in promoting type 2 immune responses by eliciting eosinophil production in 
MLNs, AT and liver, with increased levels of IL-4 and markers of M2 MACs Rentla and Chil3 in 
AT, liver and SI.  
 Loss and gain of function studies revealed the involvement of eosinophils, M2 MACs, ILCs 
and Th2 cytokines in lowering blood glucose levels, improving insulin sensitivity, increasing energy 
expenditure and decreasing adiposity (262, 263, 288-291). In our work we found an increase in IL-4 
gene expression in the AT, liver and SI of infected groups. Of note, overexpression of IL-4 has been 
shown to reduce the adipocyte layer in the skin (292). Moreover, IL-4 restored insulin sensitivity in 
the 3T3-L1 cultured cell line used for adipocyte differentiation in a dose-dependent manner (293). 
The phosphoinositide 3-kinase (PI3K)/Protein kinase-B (AKT) pathway is involved in insulin 
signalling in AT, muscle and liver, mediating cellular functions such as glucose homeostasis, lipid 
metabolism, protein synthesis and cell proliferation and survival (294). Overexpression of IL-4 
induced glucose tolerance- and insulin sensitivity-associated reductions in body weight gain and fat 
mass via activation of AKT in a PI3K-dependent manner. IL-4 also regulates adipokines and free 
fatty acids levels, implicating its role in lipid metabolism (295). Furthermore, immune cell signalling 
via IL-4/IL-13-mediated activation of STAT6 is required for N. brasiliensis expulsion (284). 
Signalling via this pathway was also found to improve insulin resistance, decrease body weight gain 
and adiposity, regulate liver metabolism and decrease inflammation in AT (291). Interestingly, 
infection with N. brasiliensis downregulated expression of genes encoding enzymes involved in lipid 
metabolism in liver and AT, leading to weight loss via an IL-4/IL-13/STAT-6-dependent manner and 
activation of M2 MAC markers (136, 296).  
 Recently, eosinophils in particular have been implicated in glucose homeostasis and energy 
expenditure. These cells play an unexpected role in metabolic homeostasis through maintenance of 
adipose M2 MACs. Absence of eosinophils resulted in increased body weight gain and impaired 
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glucose tolerance in mice (262, 263, 290). Moreover, in the absence of eosinophils, mice also exhibit 
a defect in lipid metabolism in the liver and SI, an increase in the expression of pro-inflammatory 
IFN-γ and a decrease in the expression of IL-4 and IL-13 in AT (288). 
 In our work, N. brasiliensis induced MLN, AT and liver eosinophilia, and increased gene 
expression of M2 MAC markers in AT, liver and SI. This was consistent with other studies which 
showed that infection with N. brasiliensis induced adipose eosinophilia and M2 MACs, enhanced 
glucose tolerance and lipid metabolism and ameliorated body weight gain in different mouse models 
of obesity (136, 262, 263). These studies have proposed mechanisms by which these cells might 
influence AT homeostasis. Eosinophils in bone marrow and their recruitment into WAT are largely 
controlled by IL-5. The main source of adipose IL-5 is a newly recognised population of ILC2s (262). 
These cells induce the accumulation of eosinophil-derived IL-4 which sustains M2 MACs in the 
tissue (262, 263, 290). Moreover, the chemokine eotaxin-1 expressed by adipocytes attracts and 
promotes survival of eosinophils in AT (288). Eosinophils are also implicated in the AT (mainly 
brown and beige fat) thermogenesis process, which contributes to whole body energy expenditure. 
Mechanistically, eotaxin-1 induces eosinophils to secrete IL-4/IL-13. This leads to accumulation of 
M2 MACs and proliferation of adipocytes which increases energy expenditure, reduces weight gain 
and improves glucose intolerance (297, 298). Loss of eotaxin-1, eosinophils or IL-4/IL-13 impairs 
the process (297-299).  
 In line with our results, studies utilising the HF diet model of obesity showed improvements 
in glucose intolerance of obese mice after infection with the filarial nematode L. sigmodontis or 
administration of soluble adult worm extract. This was associated with increased numbers of CD4+ 
T cells, eosinophils and M2 MACs, and depletion of eosinophils resulted in impaired glucose 
tolerance (137). Chronic S. mansoni infection and administration of schistosome soluble egg antigens 
resulted in increased numbers of AT eosinophils, M2 MACs and Th2 cytokines, and a corresponding 
decrease in body weight gain and improved insulin sensitivity in obese mice (300). Infection with the 
gastrointestinal nematode H. polygyrus also resulted in decreased body weight gain and improved 
glucose and lipid metabolism, and an associated increase in Th2/Treg immune responses in the 
MLNs, AT and SI. Moreover, infected mice on a HF diet displayed dysregulated expression of genes 
and proteins involved in energy expenditure and lipid metabolism in AT and liver (134, 135). 
This study has revealed that chronic infection with N. brasiliensis protects against metabolic 
disorders in mouse models of diet-induced T2D. We have established that N. brasiliensis reduces 
body weight gain, promotes peripheral glucose uptake and specific glucose sensitivity. Through 
analysis of immune cell composition at the cellular level, we show that N. brasiliensis infection 
promotes eosinophil accumulation and Th2 responses in MLNs, AT, liver and SI. Mechanistically, 
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the increase in eosinophil numbers in mice fed a HGI or HF diet following N. brasiliensis infection, 
may be the result of local and systemic increases in eosinophils and Th2 cytokines, as well as 
increases in M2 MAC numbers that regulate many key events involved in the control of metabolic 
homeostasis. It is not yet clear whether the eosinophil-mediated regulation of obesity-induced insulin 
resistance and AT inflammation is due to the direct and primary effects of eosinophils on insulin 
resistance or due to secondary effects of eosinophils on changes in body weight and adiposity. Further 
studies are required to elucidate the functions of helminth-induced eosinophils in terms of their 
beneficial and detrimental effects in driving metabolic reprogramming, and the therapeutic utility of 
this phenomenon for treating the global epidemic of metabolic disorders. 
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Diabetes is recognised as the world’s fastest growing chronic condition. The number of people 
with T2D is growing all over the world. Helminth infections have been shown to be associated with 
a lower prevalence of T2D, mainly due to their ability to induce a type 2 immune response. Therefore, 
to understand the molecular mechanisms that underlie the development of T2D-induced insulin 
resistance, we treated mice fed on normal or diabetes-promoting diets with Nippostrongylus 
brasiliensis excretory/secretory products (ES). We demonstrated that treatment with crude adult 
(AES) or infective L3 ES (L3ES) from N. brasiliensis improved glucose tolerance and attenuated 
body weight gain in mice fed a HGI diet. In addition, we found for the first time that N. brasiliensis 
ES treatment was associated with type 2 immune responses measured by an increase of eosinophils 
and IL-5 in peripheral tissue but not IL-4 and with a decrease in the level of IL-6 in AT while increase 
in its level in the liver	
These data highlight a role for N. brasiliensis ES in modulating the immune response 
associated with T2D, and suggest that N. brasiliensis ES contain molecules with therapeutic potential 
for treating metabolic syndrome and T2D. 
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T2D is a metabolic disease resulting from defects in protein, fat and carbohydrate metabolism 
and elevated levels of glucose in the blood that lead to impairment in insulin action and to relative 
deficiency in insulin secretion (3). The incidence of T2D is increasing in all regions of the world. 
According to the International Diabetes Federation (IDF), there were 424.9 million people with 
diabetes in 2017 and this number is expected to reach 628.6 million people by 2045, with T2D 
accounting for 90% of these cases (3).  
It is well established that helminth infection induces Th2 and Treg immune responses in 
infected hosts as a survival strategy for these chronic pathogens (301). The resulting immune response 
suppresses immunopathology induced by infection with these large parasites but also contributes to 
the overall protection against immune mediated diseases (80). It is also becoming apparent that 
helminth secretions or excretory/secretory (ES) products include potent factors that can modulate the 
host’s immune response, contributing to the control or prevention of inflammation-mediated diseases 
(164). Recently, in a proteomic analysis conducted in our lab, almost 200 ES proteins from different 
developmental stages of the hookworm Necator americanus were identified (302). Sperm coating 
protein-like extracellular proteins (SCP/TAPS) also known as Venom allergen-like (VAL) or 
Activation-associated Secreted Proteins (ASPs) and different mechanistic classes of proteases were 
over-represented, and these proteins shared different degrees of homology with proteins from other 
related nematodes such as A. caninum, H. polygyrus, and N. brasiliensis (302). ES products released 
by hookworms drive an immunoe-regulatory environment characterised by a polarisation towards the 
production of anti-inflammatory cytokines such as IL-10 and TGFβ as well as Treg cells, ILC2s, 
tolerogenic DCs, and M2 MACs (303, 304). Indeed, it has been previously reported that crude ES of 
the adult hookworm A. caninum (AcES), as well as a recombinant version of the most abundant AcES 
protein AIP-1, and AcES low molecular weight metabolites were all capable of reducing chemically-
induced colitis in mice (169, 305-307). This was associated with induction of Th2/anti-inflammatory 
cytokines such as IL-4, IL-5, IL-10 (169), TGF-β and thymic stromal lymphopoietin (TSLP) (305), 
and downregulation of Th1/pro-inflammatory cytokines such as IL-6, IL-17, IFN-γ (169), and TNF-
α (305), and recruitment of M2 MACs, eosinophils (169) and Treg cells (305) to the site of ES 
administration (169, 305). It has also been shown that the recombinant protein Ac-AIP-2, one of the 
most abundant AcES proteins, suppressed airway inflammation in a mouse model of asthma via 
induction of tolerogenic DCs and FoxP3+ Tregs (180). ES products of another GI nematode, H. 
polygyrus (HES) also impaired DC function and induced Treg cells (308, 309). ES products of N. 
brasiliensis have also been found to modulate DCs, favouring the induction of Th2 immune responses 
(153). Moreover, in a recent study, extracellular vesicles from N. brasiliensis were shown to protect 
against TNBS-induced colitis in mice. This was associated with suppression of the inflammatory 
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cytokines IL-6, IL-1β, IFNγ and IL-17a and an increase in the anti-inflammatory cytokine IL-10 
(163). Furthermore, ES products from adult N. brasiliensis (171), and recombinant forms of the 
cysteine protease inhibitors Nippocystatin (rNB-Cys) from N. brasiliensis and (rHp-CPI) from H. 
polygyrus suppressed antigen-specific antibody production (172) and IFNγ production (310), and 
simultaneously induced ES-specific Th2 immune responses (171) in ovalbumin-immunised mice 
(171, 172, 310). It has also been revealed that the filarial secreted protein ES-62 inhibited pro-
inflammatory Th1 cytokines (i.e. TNF-α, IL-6 and IFNγ) and suppressed severity and progression of 
collagen-induced arthritis (CIA) in vivo using DBA/1 mice in a murine model of rheumatoid arthritis 
(RA), and in vitro using synovial fluid and peripheral blood mononuclear cells (PBMCs) from RA 
patients (311). ES-62 administered to mice also induced M2 MACs and IL-10-producing B cells, and 
decreased the levels of IL-22 in the kidney that suppressed development of proteinuria and protected 
against kidney damage in a mouse model of systemic lupus erythematosus (312).  
In the context of diabetes, the ES products from different parasites have been shown to confer 
protection against T1D and T2D. For instance, the ES products of F. hepatica, and S. mansoni SEA 
prevented T1D in NOD mice via induction of Bregs, Tregs, M2 MACs and DCs, and increased IL-4, 
IL-10 and TGF-β levels (184, 185). Moreover, treatment with SEA (138), LNFPIII glycan from SEA 
(also found in human breast milk) (188), SEA T2 RNase recombinant protein-derived ω1 (ω1) (313) 
or soluble products from Trichuris suis (TsSP) (314) improved insulin sensitivity and suppressed 
liver lipogenesis in HF diet-induced obesity in mice. This was associated with increased numbers of 
ILC2s, eosinophils and M2 MACs and increased levels of Th2 cytokines and the alarmin IL-33 in 
AT and liver (138, 188, 313, 314). In another study, administration of somatic extract from the filarial 
nematode L. sigmosoides improved metabolic homeostasis and insulin sensitivity in a murine obesity 
model. This was also associated with increase in the eosinophils, M2 MACs, ILC2s, and expression 
of Arg-1, Foxp3, Gata3 and IL-10 (137). In a recent study, using a mouse model of T2D, researchers 
found that administration of S. japonicum SEA protect against T2D via induction of Tregs and Th2 
immune responses, which was characterised by an increase in the frequency of CD25+Foxp3+ T cells, 
and the expression of IL-4 and IL-5 in the spleen of the treated groups (315).  
In the present study, we describe a role for ES products from the gastrointestinal nematode N. 
brasiliensis in modulating the immune response associated with T2D. Intraperitoneal injection of N. 
brasiliensis ES resulted in reduced glucose levels and reduced body weight gain in a mouse model of 
T2D, which was mediated by activation of systemic and local eosinophils and IL-5 but not IL-4. N. 
brasiliensis ES administration also decreased the levels of IL-6 in AT but increased them in the liver. 
Together, these data highlight for the first time the importance of N. brasiliensis ES products in 
modulating the immune response associated with T2D. 
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3.3. Materials and Methods 
3.3.1. Ethics statement 
All procedures were approved by the JCU Animal Ethics Committee, ethics application 
number A2244. 
3.3.2. Animals and diet 
Male C57BL/6 wild-type (WT) (JCU Townsville) mice were used. At the age of 5 weeks mice 
were separated into 2 main groups: one group was fed a normal control (NC) diet and the other group 
was fed a high glycaemic index (HGI) diet (SF03-30; Speciality Feeds, Western Australia) to induce 
T2D. 
3.3.3. ES preparation and administration 
For preparation of the crude L3ES proteins, the N. brasiliensis life cycle was maintained in 
our laboratory at James Cook University (Cairns). Briefly, faeces from N. brasiliensis-infected rats 
were collected from days 5-9 post-infection. Egg-containing faeces were mixed with an equal amount 
of water and charcoal, distributed into Petri dish plates and incubated at 26°C. One week after 
incubation, L3 were collected from the faecal/charcoal culture plate, washed three times with PBS, 
then three times with PBS supplemented with 5% antibiotic-antimycotic (AA) (Gibco). L3 were then 
transferred into a flat bottom 24 well-plate, cultured in serum-free RPMI media (Gibco) supplemented 
with 2% AA and 1% D-glucose (Sigma) and incubated at 37°C and 5% CO2 at a density of 500 
L3/well. The supernatant was then collected daily from days 1-10, ensuring motility of the worms at 
all times. Supernatants were stored at -30°C before protein concentration and lipopolysaccharide 
(LPS) content were determined. 
For adult ES (AES) preparation, rats were infected with 3,000 L3 N. brasiliensis. At day 6 
post-infection rats were euthanized and the small intestine collected and opened in a Petri dish 
containing RPMI and incubated at 37°C and 5% CO2 for 2 hours. Adult worms were then collected, 
washed three times with PBS followed by three washes with PBS supplemented with 5% AA and one 
wash with RPMI media supplemented with 2% AA. 100 worms/well were then transferred into a flat 
bottom 24 well-plate and incubated in RPMI media supplemented with 2% AA, 1% D-glucose and 
1% Glutamax at 37°C and 5% CO2. After 24h the supernatant was discarded to minimise 
contamination with host proteins and replaced with new media. AES was collected at day 2 and 
replaced subsequently every day until day 10. Supernatants were stored at -30°C before protein 
concentration and lipopolysaccharide (LPS) content were determined .  
Amicon ultrafiltration 3 kDa tubes (Thermo scientific) were used for protein concentration 
and buffer exchange with PBS. The Pierce BCA protein assay kit (Thermo scientific) was used for 
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quantification of the protein content following the manufacturer’s instructions. The Pierce LAL 
Chromogenic Endotoxin Quantification Kit (Thermo Scientific) was used for the quantification of 
LPS in AES and L3ES preps. Firstly, AES and the L3ES were incubated with 1% Triton-114 at 4°C 
on a rotor (Ratek) overnight with low constant stirring. After that, ES proteins were incubated at 37°C 
for 10 minutes using a dry bath incubator (Major Science), followed by centrifugation in a Microfuge 
22R centrifuge (Beckman Coulter) at 14,000 g for 5 minutes. The top layer was collected and 
prepared for LPS quantification. Briefly, 4 standards were prepared, ranging from 1- 0.1 EU/ml. 
Then, 50 μl of the standards and ES samples were added in duplicate to a 96 well plate and incubated 
at 37°C and 5% CO2 for 5 minutes Subsequently, 50 μl of Limulus Amebocyte Lysate was added and 
the plate was incubated at 37°C for 10 minutes, followed by addition of 50 µl of Chromogenic 
Substrate and incubation for 6 minutes at 37°C. Then, 50 μl of the stop solution was added and the 
results were read on a BMG Polarstar Omega fluorescence microplate reader at 405 nm. The ES 
proteins were suitable for use when the LPS content was below 5 EU/mg of protein.  
The ES products were administered to mice intraperitoneally twice weekly from week 6 until 
the end of the experiment at a dose of 1 mg/kg. Control groups were administered intraperitoneally 
with the same volume of PBS. 
3.3.4. Fasting Blood Glucose (FBG) and Oral Glucose Tolerance Test (OGTT) 
The FBG was measured in 6-hour unfed mice. Blood sampling was performed by tail bleeding 
using Accu-Check® Performa (Roche). Mice were considered diabetic when glucose levels reached 
> 12.0 mmol/L. The OGTT was measured in 6-hour unfed mice, after initial blood collection (time 
0). Mice were administered D-glucose orally (2 g/kg body weight) by gavage. Blood sampling was 
performed by tail bleeding at 15, 30, 60, 90, and 120 minutes after administration of glucose. 
3.3.5. Tissue collection and cytokine analysis  
The AT, liver and small intestine were collected and washed with PBS; one cm of the tissue 
was combined with 0.5 mL of PBS, homogenised using a TissueLyzer (QIAGEN), centrifuged and 
supernatants stored at -80°C until use. The ELISA Ready-Set-Go set (eBioscience) for the cytokines 
IL-4, IL-5, IL-6 was used following the manufacturer’s instructions of standard sandwich ELISA 
protocols. In brief, a 96-well flat bottom plate was coated with 50 μl of capture antibody and incubated 
overnight at 4°C. The plate was then washed 3 times with washing buffer. Then, 50 μl of blocking 
reagent was added and the plate was incubated for 1 hour at room temperature. The washing step was 
performed twice. 50 μl from the samples and from serial dilution of the standards were added to the 
plate and incubated overnight at 4°C, followed by 3 more washing steps. Subsequently, 50 μl of 
detection antibody was added, incubated for 30 minutes at room temperature and followed by 3 more 
washes. Then, 50 μl of substrate solution was added and incubated for 15 minutes at room 
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temperature. Finally, 50 µl of stop solution (1M HCl) was added and the absorbance was read on a 
BMG Polarstar Omega at 450 nm. The lower detection limit for all cytokines was  ≥ 6 pg/ml. 
3.3.6. Isolation of the mesenteric lymph nodes, adipose tissue and liver for flow cytometry 
analysis 
In brief, epididymal fat pads or liver from male mice fed a NC or HGI diet were removed and 
minced into small pieces, then transferred to 50 ml conical tubes containing 1 ml DPBS (0.5% BSA) 
(Sigma) and 3 ml collagenase type II (Life Technologies), and incubated on a rotational shaker (200 
rpm) at 37°C for 35 minutes The AT or liver homogenates were filtered through a 70 μm strainer 
into a new tube and centrifuged at 500 g for 10 minutes at 4°C. Following centrifugation, the 
supernatant was discarded and the pellet was resuspended in 1× red blood cell lysis buffer (Sigma), 
followed by a washing step with 5 ml FACS buffer and centrifugation at 500 g for 10 minutes at 4°C 
(316, 317). MLNs were removed and filtered through a 70 μm strainer. Cell viability was assessed 
by Trypan Blue and cells were blocked for FACS analysis. Cell surface marker analysis was 
performed using flow cytometry. Single-cell suspensions prepared from MLNs, AT and liver were 
collected from mice at the times indicated. Cell surface markers were stained for 30 minutes at 4°C 
with CD3/CD19-CF594 (Clone:145-2C11,1D3) F4/80-APC (Clone: T45-2342), CD11c-FITC 
(Clone: HL3), CD301-pecy7 (Clone: LOM-14), CD64-PerCp-Cy5.5 (Clone: X45-5/7.1), CD11b-
BV650 (Clone: M1/70), Ly6G-efluor700 (Clone: 1A8) and Siglec-F-PE (Clone: E50-2440) (BD 
Bioscience). All antibody incubations were performed at 4°C for 30 minutes (isotype controls were 
included). Data were acquired using a BD FACS Aria with BD FACS DIVA software (BD 
Bioscience) and analysed using FlowJo software (Tree Star, Inc). 
3.3.7. Data analysis  
Data were tested for statistical significance using GraphPad Prism software (version 6). The 
Mann-Whitney U test was applied to test differences between two unpaired groups with 
nonparametric distribution for statistical significance. Data that were normally distributed were tested 
for statistical significance using the unpaired t test for comparisons of two groups or the ANOVA test 
followed by the Holm-Sidack multiple-comparison test to compare more than two groups. Values of 
p < 0.05 were considered statistically significant. Results are expressed as mean with SEM or means 








3.4.1. Treatment with either AES or L3ES from N. brasiliensis improves glucose tolerance and 
attenuates body weight gain 
In order to address the prophylactic effect of N. brasiliensis ES on the outcome of T2D, 5 
week-old male C57BL/6 mice were used; half the mice were fed NC diet and the other half were fed 
a HGI diet to induce T2D for up to 30 weeks. Mice were treated twice weekly with N. brasiliensis 
AES or L3ES at a dose of 1 mg/kg starting at week 6 until the end of the experiment. Mice treated 
with AES or L3ES showed a significant decrease in the level of FBG compared to the control groups 
(Fig. 3.4.1A). Moreover, results from the OGTT test showed that NC and HGI diet groups treated 
with AES or L3ES had significantly lower levels of blood glucose at all time points (Fig. 3.4.1B and 
C). Reduction in body weight gain was also observed as a result of the treatment. Mice on either NC 
or HGI diet treated with AES or L3ES gained less weight compared to control groups (Fig. 3.4.1D 



































































































































































Fig 3.4.1. Treatment with either AES or L3ES from N. brasiliensis improves glucose tolerance 
and attenuates body weight gain. 
C57/BL6 mice were fed NC or HGI diet and treated frequently with L3ES or AES of N. brasiliensis. (A) 
FBG; (B) OGTT, ND; (C) OGTT, HGI; (D) Weight, NC; (E) Weight, HGI. Statistical significance was 
determined with Student’s t test or Tow-way analysis of variance (ANOVA). Data are expressed as mean ± 
SEM or as means ± SD and are representative of 1 experiment where n = 10/group. *p < 0.05, **p < 0.01. 
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3.4.2. Treatment with N. brasiliensis ES induces tissues eosinophilia and Th2 immune responses 
Mice were fed an HGI diet and treated with AES or L3ES of N. brasiliensis as described 
above. At the end of the experiment, various tissues were collected such as MLNs, AT and liver for 
further characterisation of the Th2 immune response. Interestingly, in response to N. brasiliensis AES 
or L3ES injection, there was a significant increase in the total number of eosinophils in the mLNs, 
AT and liver of the HGI and NC diet groups compared to the control group (Fig. 3.4.2A).   
To assess whether the increase in the eosinophils numbers induced a potent Th2 cytokine response 
by elevating cytokine levels in AT and liver we analysed the levels of several cytokines by ELISA. 
Injection of AES or L3ES significantly increased the levels of Th2 cytokines, measured by IL-5 in 
AT and liver (Fig. 3.4.2B and C) compared to the naïve groups. However, our study showed no 
significant differences in the levels of IL-4 between treated and un-treated groups (Fig. 3.4.2B, and 
C). Moreover, groups treated with either AES or L3ES had significantly lower levels of IL-6 in the 




































Fig 3.4.2. Treatment with N. brasiliensis ES induces tissues eosinophilia and Th2 immune 
responses. 
C57/BL6 mice were fed normal control (NC) or high glycaemic index (HGI) diet and treated twice weekly with 
L3ES or AES of N. brasiliensis. (A) Eosinophil frequency and total numbers in mLNs, AT and Liver. (B) AT 
IL-4, IL-5 and IL-6 expression. (C) Liver IL-4, IL-5 and IL-6 expression. Statistical significance was determined 
with Student’s t test. Data are expressed as mean ± SEM and are representative of 1 experiment where n = 

















































































































































Incidence and prevalence of diabetes is on the rise globally, imposing a drastic socio-
economic burden on public health (3). Many researchers have reported that helminths and their 
secretions can modulate the host’s immune response, which might have beneficial effects in 
controlling or preventing the inflammatory responses associated with immune-mediated diseases 
(164). Understanding the mechanisms by which helminth ES products can skew the immune response 
away from a T2D-promoting phenotype is critical for the rational design of preventative therapies 
against this disease. It has been found that N. brasiliensis and its secreted products are able to induce 
a Th2 immune response. This was characterised by an increase in a systemic and localised 
eosinophilia, ILC2s, M2 MACs, DCs, and increased production of cytokines such as IL‐4, IL‐5, IL‐
9, IL‐10 and IL‐13 (89, 153, 154, 280). In addition, it has been previously reported that administration 
of SEA from S. mansoni or S. japonicum (138, 185, 315) or LsAg from the adult filarial nematode L. 
sigmodontis (137) protect against T1D and T2D in mice (185, 315) and improved insulin sensitivity 
in obese mice (137, 138).  
In the present study, we showed that administration of N. brasiliensis crude ES from adult 
and L3 developmental stages attenuated the clinical indicators of T2D in the HGI diet mouse model. 
Our data showed that AES and L3ES administration ameliorates glucose intolerance and attenuates 
body weight gain in the treated groups. Previous findings using SEA from S. japonicum significantly 
reduced the level of blood sugar, however the level was still higher than those on a normal diet (315). 
This was consistent with our results, as we also found that treatment with AES or L3ES of N. 
brasiliensis significantly reduced the blood glucose level in the diabetic group, although they were 
still higher than those mice fed a normal chow diet.  
Our results showed non-significant differences in the levels of IL-4 in the liver and adipose 
tissue of treated groups compared to their naïve counterparts; however we found a significant increase 
in the number of eosinophils in the MLNs, AT and liver with a significant increase in the level of IL-
5 in the AT and liver. IL-5 is responsible for the release, expansion and survival of eosinophils (318-
320), and N. brasiliensis infection is characterised by high eosinophil production induced by IL-5 
secreted from CD4+ T cells (285). Importantly, it has been demonstrated that AT eosinophils are 
highly dependent on IL-5 (41) and eosinophils play an unexpected role in metabolic homeostasis 
through maintenance of adipose M2 MACs (37). As with eosinophil deficiency, IL-5 deficiency in 
mice impairs eosinophil accumulation in AT, and mice develop increased body fat, impaired glucose 
tolerance and insulin resistance when fed a HF diet (41). Moreover, ILC2s have been found to play 
an important role in sustaining AT eosinophils (41). Infection with N. brasiliensis induces adipose 
eosinophilia and enhances glucose tolerance in mice fed with a HF diet via activation of AT ILC2s, 
which induces IL-5 production that leads to accumulation of eosinophils in the AT (41). Deletion of 
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IL-5 resulted in the loss of eosinophil activation in AT (41) and impaired glucose tolerance (37). It 
has been reported that N. brasiliensis infection protects against experimental autoimmune 
encephalomyelitis (EAE) via increased IL-5 levels and subsequent increases in eosinophils and 
CD4+CD25+ Tregs. Moreover, anti-IL-5 or anti-CD25, but not anti-IL-4, can abolish the beneficial 
effect of the parasitic infection (321). Furthermore, treatment of mice with F. hepatica ES products 
attenuates EAE independently of IL-4 and IL-10, but via production of IL-33 and IL-5, which 
promoted accumulation of eosinophils (322).  
In our study, treatment with AES or L3ES of N. brasiliensis significantly decreased the 
expression of IL-6 in AT. However, in the liver IL-6 expression was comparable between treated and 
untreated groups. In one study, treatment of intestinal pig epithelial cells in vitro with T. suis ES 
products increased the level of IL-6 and IL-10, but not IL-4 in both differentiated and undifferentiated 
cells (323). IL-6 is a multifaceted cytokine that is involved in the induction of insulin resistance and 
pathogenesis of T2D (324), and secretion of IL6 by AT resulted in the induction of hepatic insulin 
resistance (325). On the other hand, IL-6 is involved in liver regeneration and maintenance of liver 
tissue homeostasis (326). Moreover, IL-6 is required for protection against hepatic inflammation and 
insulin resistance, and lack of IL-6 reversed the effect (327, 328). Short term preincubation with IL-
6 of human PBMC stimulated with anti-CD3 and anti-CD28 antibodies led to up-regulation of IL-4 
and IL-5. However, the effect on IL-4 production gradually disappeared but the effect on IL-5 became 
more pronounced in the long term preincubation of these cells with IL-6 (329). Moreover, IL-6 
enhanced expansion and survival of antigen-stimulated CD4+ T cells and reduced their apoptosis in 
the blood, lymph nodes, spleen, liver, and lung in vivo and in vitro (330). Furthermore, in the presence 
of eosinophil-derived neurotoxin (EDN), splenocytes of TLR2+/+ mice immunized with OVA 
produced IL-5, IL-6, IL-10 and IL-13, whereas in the presence of LPS they produced IFN-γ (331). 
One possibility for the increase in liver IL-6 we observed might be the effect of IL-6 as a survival 
factor in liver tissue-mediated EDN in activation of TLR2 and expansion and survival of CD4+ T 
cells in the liver.  
Here we found that treatment with L3ES or AES from N. brasiliensis using a dose of 1 mg/kg 
twice weekly significantly decreased the level of blood glucose in diabetic mice, although levels were 
still higher than control group. We also found a significant increase in the number of eosinophils in 
the MLNs, AT and liver associated with an increase in the levels of IL-5 in AT and liver but no 
differences in the levels of IL-4 in the same tissues. Moreover, a decrease in the level of IL-6 was 
observed in AT whereas it was increased in the liver. It must be pointed out, that N. brasiliensis ES 
products induced airway eosinophilia in a dose-dependent manner (156). Moreover, we (data not 
published) and others (37, 41, 136) have found a robust increase in the systemic and peripheral 
eosinophil number, IL-4 level and IL-5 level after infection with N. brasiliensis. Infection with N. 
58	
	
brasiliensis requires parasite development through different larval stages and migration through 
different tissues, which may induce distinct mechanisms of modulating the host immune response 
that differ from the administration of its ES proteins. This might explain the differences in the ability 
of L3ES and AES to suppress T2D. So, it is worth considering the route of infection and the 
therapeutic/prophylactic dose of ES proteins. As previously mentioned, ES products induce a variety 
of immune responses that promote innate and adaptive immune cells, and these cells play very 
different roles in inducing or protecting against metabolic diseases. Understanding the precise 
immunological mechanism of action that underpins the clinically beneficial effect is now paramount. 
To our knowledge, this study is the first to uncover a novel effector response of helminth ES product-
mediated reduction of insulin resistance in a mouse model of T2D. Future work should focus on 
defining the bioactive ES components and their recombinant or synthetic production and validation.  
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T2D is a highly prevalent metabolic disorder characterised by an imbalance in the blood 
glucose level. Dysbiosis of the gut microbiome may reshape intestinal barrier functions, host 
metabolic and signalling pathways, which are directly or indirectly related to insulin resistance in 
T2D. Recently, a growing body of evidence has highlighted a role for helminth infection and/or their 
ES products in modulating the composition of the gut microbiota, which in turn might maintain and 
promote intestinal health. We demonstrated that infection with N. brasiliensis or treatment with L3ES 
or AES were associated with significant compositional changes in the gut microbiota that occurred 
at both the phylum and order level. Phyla that were particularly affected included Actinobacteria, 
Verrucomicrobia, Proteobacteria and TM7. Orders that were most impacted by infection or treatment 
with ES products included Clostridiales, Desulfovibrionales, Burkholderiales, Verrucomicrobiales 
and Coriobacteriales. The effects on microbiota composition were also impacted by diet. However, 
whether these microbiota changes are a necessary component for helminth- or -ES product- mediated 
protection against T2D is unclear and has yet to be investigated. These findings indicate that 
gastrointestinal nematode ES products hold promise as a novel intervention approach for the 
treatment of T2D. 
 




















The gut microbiota is not only essential for host metabolism but is also important in the 
maintenance of immune homeostasis (275, 332). The immune system has largely evolved as a means 
to maintain a symbiotic relationship with these highly diverse and evolving microbes. When operating 
optimally, the immune system-microbiota alliance permits the induction of protective responses to 
pathogens, and the maintenance of regulatory pathways that govern tolerance to innocuous antigens 
(241). Indeed, a decrease in our exposure to infectious agents such as helminths, and alteration of the 
gut microbiota composition has resulted in an enhanced inflammatory environment and poorly 
developed regulatory networks, and has been strongly associated with the increased incidence of 
immune mediated diseases (333). There is cumulative evidence highlighting the beneficial role of gut 
microbiota in shaping the mammalian immune system (212).  
Disturbance of the intestinal microbial community leads to altered immune responses that can 
result in various inflammatory disorders (212). Regulation of metabolic homeostasis and 
inflammation in obesity, metabolic syndrome and DM has been increasingly connected with the gut 
microbiota (226). The first evidence came from studies on GF mice, as they were resistant to obesity-
associated insulin resistance and dyslipidemia when fed a Western HF or HGI diet; however, 
colonization of these mice with microbiota from conventionally raised mice led to an increase in the 
total body fat, increased lipids in the liver and a dramatic increase in IR (227, 334, 335). Many studies 
have demonstrated differences in the composition of gut microbiota between healthy, obese and T2D 
patients. The ratio of Firmicutes to Bacteroidetes found to be changed with obesity, favoring increase 
in Bacteroidetes in some reports  (336) or decrease in its ratio in others (337) and increase in the 
Firmicutes (338). Moreover, T2 diabetic subjects had significantly lower proportions of the phylum 
Firmicutes and class Clostridia compared to control group. Also the ratio of Bacteroidetes to 
Firmicutes, as well as  the ratio of Bacteroides-Prevotella to Clostridium coccoides-Eubacterium 
rectale were correlated positively and significantly with the plasma glucose concentration (236). 
Other metagenomics association studies of gut microbiota in T2D subjects found a reduction in the 
number of Clostridiales bacteria (Roseburia species and Faecalibacterium prausnitzii) compared to 
diabetic patients (339, 340).  
A growing body of literature has linked helminth presence with microbiota diversity and 
composition (242). For instance, infection with the roundworm T. muris led to a reduction in the 
microbial α-diversity and the abundance of Bacteroidetes, specifically Prevotella and 
Parabacteroides (244), and an increase in the abundance of Proteobacteria (245), Firmicutes (244) 
and the Lactobacillus genus belonging to Firmicutes (245). Infection with H. polygyrus  increases the 
members of γ-Proteobacteria/Enterobacteriaceae group and members of the Bacteroides/Prevotella 
genera (247), as well as members of Lactobacillaceae family (249). N. brasiliensis infection reduces 
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the abundance of Firmicutes/Peptostreptococcaceae, Clostridiaceae and Turicibacteraceae and 
increases the abundance of Lactobacillaceae, Bacteroidetes/S24-7 and Actinobacteria/ 
Coriobacteriaceae. (246). Human studies also highlighted the role of helminth infection in modulating 
the composition of gut microbiota between helminth-infected and helminth-naive individuals (257, 
258, 261). CeD subjects infected with hookworm N. americanus and challenged with gluten showed 
tolerance to gluten and had increase in the intestinal microbial species richness and a trend towards 
an increase in the abundance of species within the Bacteroidetes phylum in comparison with the 
uninfected group (103-105, 258-260). This was also associated with increase in the Th2 and Tregs 
cytokines (102, 103). Moreover, increase in the abundance of Paraprevotellaceae, Mollicutes, 
Bacteroidales and α-proteobacteria was observed in subjects naturally infected with multiple 
helminths (Trichuris spp., Ascaris spp. and hookworm). However, the helminth-negative group 
showed increased abundance of Bifidobacterium (261). Furthermore, people infected with S. 
stercoralis had a higher abundance of the families Leuconostocaceae, Ruminococcaceae, 
Paraprevotellaceae and the genus Peptococcus , while the S. stercoralis-negative group showed a 
significant increase in the order Pseudomonadales/Pseudomonas and an unidentified species of the 
genus Bacteroides (257).  
In mice studies, others have highlighted a role for helminth-microbiota interaction in the 
protection against many inflammatory diseases such as allergy (250), IBD (251), arthritis (256), 
Lupus (341) and obesity (254, 255). NOD2-/- mice develop spontaneous colitis, and infection of these 
mice with T. muris or H. polygyrus inhibited growth of Bacteroides vulgatus and decreased the 
abundance of Bacteroidales/Bacteroides and Prevotella and increased the abundance of 
Clostridiales/Lachnospiraceae. Administration of a mixture of clusters IV, XIVa and XVIII 
Clostridiales and Erysipelotrichales strains to NOD2-/- mice can inhibit colonization of B. vulgatus 
(251). Mice infected with H. polygyrus  then challenged with HDM, this altered the intestinal bacterial 
communities that attenuated allergic airway inflammation (250). Suppression in obesity was also 
observed when mice fed HF diet then infected with H. polygyrus   (254). This was associated with an 
increase in order Clostridiales (250), Bacillus and Escherichia species as well as in the Proteobacteria 
phylum (254). Infection of obese mice with S. venezuelensis improved insulin sensitivity and was 
associated with an increase in Firmicutes/Lactobacillus spp. and a decrease in Bacteroidetes (255). 
Administration of the A. viteae immunomodulator ES-62 maintained a healthy microbiome diversity 
and normalised gut microbiota communities, mainly Clostridiaceae, Lachnospiraceae and 
Ruminococcaceae, that protect against arthritis (256). The anti-inflamamtory moiety of ES-62 is 
phosphorylcholine, and treatment with TPC (synthetic tuftsin-phosphorylcholine) induced remission 
of lupus in mice, and was associated with a decrease in the abundance of Akkermansia and an increase 
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in the abundance of several genera, including Turicibacter, Bifidobacterium, unclassified 
Mogibacteriaceae, unclassified Clostridiaceae, Adlercreutzia, Allobaculum and Anaeroplasma (341).  
There is, therefore, a real need to uncouple this three-way relationship between helminths, 
microbiome and inflammatory/metabolic diseases. Thus, we aimed to investigate whether infection 
with N. brasiliensis has a role in altering the composition of the gut microbiota, and whether this 
alteration might have an impact on maintenance of gut homeostasis in T2D mice. 
4.3. Materials and Methods: 
4.3.1 Ethics statement: 
All procedures were approved by the JCU Animal Ethics Committee, ethics application 
number A2244. 
4.3.2 Animals and Diet: 
Male C57BL/6 wild-type (WT) (JCU Townsville) mice were used. To induce T2D, at the age 
of 5 weeks, mice were either fed a HGI diet (SF03-30; speciality feeds, Western Australia) or a HF 
diet (SF07-066; speciality feeds, Western Australia) while animals from the control group were fed 
a normal control (NC) diet. 
4.3.3. Whole worm infection 
N. brasiliensis life cycle was maintained in our laboratory at James Cook University (Cairns). 
Briefly, faeces from N. brasiliensis-infected rats were collected from days 5-9 post-infection. Egg-
containing faeces were mixed with an equal amount of water and charcoal, distributed into Petri dish 
plates and incubated at 26°C. One week after incubation, L3 were collected from the faecal/charcoal 
culture plate, washed three times with PBS, then the mice were injected subcutaneously above the 
upper thoracic spine with 500 L3 of N. brasiliensis using a 21-gauge needle once a month, starting at 
6 weeks of age until the end of the experiment (30 weeks).  
4.3.4. Administration of AES and L3ES products 
For preparation of the crude L3ES proteins, the N. brasiliensis life cycle was maintained in 
our laboratory at James Cook University (Cairns). Briefly, faeces from N. brasiliensis-infected rats 
were collected from days 5-9 post-infection. Egg-containing faeces were mixed with an equal amount 
of water and charcoal, distributed into Petri dish plates and incubated at 26°C. One week after 
incubation, L3 were collected from the faecal/charcoal culture plate, washed three times with PBS, 
then three times with PBS supplemented with 5% antibiotic-antimycotic (AA) (Gibco). L3 were then 
transferred into a flat bottom 24 well-plate, cultured in serum-free RPMI media (Gibco) supplemented 
with 2% AA and 1% D-glucose (Sigma) and incubated at 37°C and 5% CO2 at a density of 500 
65	
	
L3/well. The supernatant was collected daily from days 1-10, ensuring motility of the worms at all 
times. Supernatants were stored at -30°C before protein concentration and lipopolysaccharide (LPS) 
content were determined. 
For adult ES (AES) preparation, rats were infected with 3,000 L3 N. brasiliensis. At day 6 
post-infection rats were euthanized and the small intestine collected and opened in a Petri dish 
containing RPMI and incubated at 37°C and 5% CO2 for 2 hours. Adult worms were then collected, 
washed three times with PBS followed by three washes with PBS supplemented with 5% AA and one 
wash with RPMI media supplemented with 2% AA. 100 worms/well were then transferred into a flat 
bottom 24 well-plate and incubated in RPMI media supplemented with 2% AA, 1% D-glucose and 
1% Glutamax at 37°C and 5% CO2. After 24h the supernatant was discarded to minimise 
contamination with host proteins and replaced with new media. AES was collected at day 2 and 
replaced subsequently every day until day 10. Supernatants were stored at -30°C before protein 
concentration and lipopolysaccharide (LPS) content were determined.  
Amicon ultrafiltration 3 kDa tubes (Thermo scientific) were used for protein concentration 
and buffer exchange with PBS. The Pierce BCA protein assay kit (Thermo scientific) was used for 
quantification of the protein content following the manufacturer’s instructions. The Pierce LAL 
Chromogenic Endotoxin Quantification Kit (Thermo Scientific) was used for the quantification of 
LPS in AES and L3ES preps. Firstly, AES and the L3ES were incubated with 1% Triton-114 at 4°C 
on a rotor (Ratek) overnight with low constant stirring. After that, ES proteins were incubated at 37°C 
for 10 minutes using a dry bath incubator (Major Science), followed by centrifugation in a Microfuge 
22R centrifuge (Beckman Coulter) at 14,000 g for 5 minutes. The top layer was collected and 
prepared for LPS quantification. Briefly, 4 standards were prepared, ranging from 1- 0.1 EU/ml. 
Then, 50 μl of the standards and ES samples were added in duplicate to a 96 well plate and incubated 
at 37°C and 5% CO2 for 5 minutes Subsequently, 50 μl of Limulus Amebocyte Lysate was added and 
the plate was incubated at 37°C for 10 minutes, followed by addition of 50 µl of Chromogenic 
Substrate and incubation for 6 minutes at 37°C. Then, 50 μl of the stop solution was added and the 
results were read on a BMG Polarstar Omega fluorescence microplate reader at 405 nm. The ES 
proteins were suitable for use when the LPS content was below 5 EU/mg of protein.  
ES products were administered intraperitoneally twice weekly from week 6 until the end of 
the experiment at a dose of 1 mg/kg. Control groups were administered intraperitoneally with the 






4.3.5. DNA extraction and bacterial 16S rRNA Illumina sequencing  
Small intestine samples were collected and stored immediately at -80°C for further analysis. 
DNA extraction and 16s rRNA sequencing were performed by the Australian Centre for 
Ecogenomics, University of Queensland, Brisbane. In brief, a total of 50-100 mg of tissue sample 
was disrupted mechanically using a Powerlyzer 24 at 2,000 g for 5 minutes. A QIAamp 96 
PowerFaecal QIAcube HT Kit was used to process the resulting lysate as per the manufacturer’s 
instructions, and a Qubit assay (Life Technologies) was used for measuring DNA concentration, 
which was then adjusted to a concentration of 5 ng/µl. The 16S rRNA gene was targeted, using the 
803 forward primer (5’- TTAGAKACCCB NGTAGTC -3’) and 1392 reverse primer (5’- 
ACGGGCGGTGWGTRC -3’) to cover the V6-V8 regions. Preparation of the 16S library was 
performed following the protocol outlined in the Illumina guide. In the first stage, 466 bp of the PCR 
products were amplified. The resulting PCR amplicons were then purified using Agencourt AMPure 
XP beads (Beckman Coulter). The purified DNA was indexed with unique 8cbp barcodes using the 
Illumina Nextera XT 384 sample Index Kit A-D (Illumina FC-131-1002). The Qiagen QIAquick Gel 
Extraction Kit was used for the isolation of the indexed amplicons as per the manufacturer’s 
instructions for the specific band at 450 bp (running at 610 bp with the adaptor sequence). Then, the 
resulting purified indexed amplicons were pooled together in equimolar concentrations and 
sequenced on a MiSeq Sequencing System (Illumina) using paired end (2 x 300 bp) sequencing with 
V3 chemistry in the Australian Centre for Ecogenomics according to the manufacturer’s protocol. 
Passing quality control of resulting sequence is determined as 10,000 raw reads per sample prior to 
data processing and passing quality control metrics in line with Illumina supplied reagent metrics of 
overall Q30 for 600cbp reads of >70%.  
4.3.6. Bioinformatics and statistical analysis 
Raw reads were run through fastqc for quality control, Trimmomatic (342) for adapter 
trimming and low quality base removal, QIIME (343) for Operational Taxonomic Units (OTUs) 
generation, and BLAST (344) for OTU identification. Within QIIME, low-quality reads are filtered 
with all remaining sequences de-multiplexed and chimeric sequences removed using UCHIME (345). 
Sequences were subsequently clustered into OTUs on the basis of similarity to known bacterial 
sequences in the Greengenes database (346) (cut-off: 97% sequence similarity) using the UCLUST 
software (347). 
For each biom file, the taxonomic observation and metadata was added using biom API (348) 
which was next loaded into the R package phyloseq (349). Within phyloseq, the DESeq2 (350) API 
was called and a list of most differentially expressed bacteria generated for all possible pairings of 
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conditions (NC and NC infected with N. brasiliensis, T2D mice fed HGI and T2D mice fed HGI 
infected with N. brasiliensis or T2D mice fed HF and T2D mice fed HF infected with N. 
brasiliensis)(NC and NC L3ES or NC AES, T2D fed HGI and T2D fed HGI L3ES or T2D fed HGI 
AES). All subsequent plots were generated using ggplot2 and Calypso online software (version 8.84) 
(http://cgenome.net/calypso/) (351). Within Calypso, data were normalised by total sum 
normalisation (TSS) combined with square root transformation. Multivariate redundancy analysis to 
overall differences in the microbial profile between groups and Adonis based on the Bray-Curtis 
dissimilarity were used. Differences in bacterial alpha diversity (Shannon diversity) and richness 
between groups were used. Values of p < 0.05 were considered statistically significant following false 
discovery rate (FDR) correction. Differences in the bacterial taxa abundance between groups were 
assessed using ANOVA-like differential expression analysis (ALDEx2) and quantitative 
visualisation of phyla abundance.  
 
4.4. Results 
4.4.1. Infection with N. brasiliensis resulted in altered microbial profile in normal control and 
T2D mice 
We wanted to address the effect of infection with N. brasiliensis on the composition of the 
gut microbiota in two different models of diet-induced T2D in mice (HGI and HF diet). At week 5 of 
age, male C57BL/6 mice were kept on a NC diet or were fed either a HGI or a HF diet for up to 30 
weeks to induce T2D. Infection with N. brasiliensis started at week 6 and continue once every month 
until the end of the experiment. Small intestine samples were collected at the end of the experiments 
to determine the differences in the composition of gut microbiota between infected and uninfected 
groups. Multivariate redundancy analysis (RDA) on OTU level showed a different clustering in the 
microbial profile of the infected groups compared to the uninfected control groups for all diets. 
Adonis analysis also confirmed the differences between infected and uninfected groups on the NC, 
HF and HGI diets based on Bray-Curtis and spearman index (Table 1). The α-diversity and microbial 
richness were not statistically significant between naïve groups and N. brasiliensis infected groups 

























4.4.2. Infection with N. brasiliensis alters the abundance of bacterial taxa in different diets 
In general, there were no significant differences in the most dominant phyla of the infected 
groups compare to their uninfected counterparts in all diets used in this study (Fig. 4.4.2). In regard 
to the NC diet groups, abundance of Actinobacteria phylum was significantly decreased in the N. 
brasiliensis infected (NCNb) group compared to the uninfected naïve group (NCN). The abundance 
of both Firmicutes and Bacteroidetes phyla was slightly increased in NCNb group compare to their 
NCN group but were not significantly different and no changes in any other phyla were detected (Fig. 
4.4.2A). No significant changes at the phylum level were found between HF diet groups infected with 
N. brasiliensis (HFNb) and the uninfected naïve group (HFN) in all phyla detected (Fig. 4.4.2B). A 
significant decrease in the abundance of Verrucomicrobia phylum and a significant increase in the 
abundance of Proteobacteria phylum were detected in the HGI groups infected with N. brasiliensis 
(HGINb) compared to the uninfected naïve group (HGIN) (Fig. 4.4.2C). HGINb also showed a trend 
towards an increase in the abundance of Actinobacteria phylum while there was a decrease in the 
TM7 phylum; however, these changes were not statistically significant. No significant differences 
were detected in any other phyla.  
At the order level, N. brasiliensis infection significantly increased the abundance of the 
Clostridiales group, belonging to the Firmicutes phylum, in both the NCNb group and the HFNb 
group compared to the uninfected naïve groups (Fig. 4.4.3A and 4.4.3B). The abundance of 
Fig 4.4.1. Infection with N. brasiliensis resulted in altered microbial profile in normal control 
and T2D mice. 
C57/BL6 mice were fed a normal control (NC) diet or either a high fat (HF) or high glycaemic index (HGI) 
diet and infected once monthly with 500 L3 of Nippostrongylus brasiliensis. Multivariate redundancy 
analysis. (A) Normal control naïve (N) group and normal control N. brasiliensis (Nb) infected group. (B) High 
fat naïve (N) group and high fat N. brasiliensis (Nb) infected group. (C) High glycaemic index naïve (N) 
group and high glycaemic index N. brasiliensis (Nb) infected group. The data are representative of two 









Bifidobacteriales belonging to the Actinobacteria phylum significantly decreased in the NCNb group 
compared to the NCN group (Fig. 4.4.3A). N. brasiliensis infection also caused a significant elevation 
in the abundance of Desulfovibrionales and Burkholderiales orders belonging to the Proteobacteria 
phylum in both the HFNb and HGINb groups, respectively, compared to the uninfected naïve groups 
(Fig. 4.4.3B and 4.4.3C). The abundance of both the CW040 order belonging to the TM7 phylum and 
the Verrucomicrobiales order belonging to the Verrucomicrobia phylum significantly decreased in 


















Fig 4.4.2. Infection with N. brasiliensis alters the abundance of bacterial phyla in different diets. 
C57/BL6 mice were fed either a normal control (NC), high fat (HF) or high glycaemic index (HGI) diet and 
infected once monthly with 500 Nippostrongylus brasiliensis L3. (A) Quantitative visualisation of phylum 
abundance between normal control naïve (NCN) and normal control N. brasiliensis (NCNb) infected groups; 
(B) Quantitative visualisation of phylum abundance between high fat naïve (HFN) and high fat N. brasiliensis 
(HFNb) infected groups; (C) Quantitative visualisation of phylum abundance between high glycaemic index 
naïve (HGIN) and high glycaemic index N. brasiliensis (HGINb) infected groups. P value based on ANOVA-





































Fig 4.4.3. Infection with N. brasiliensis alters the abundance of bacterial order in different 
diets. 
C57/BL6 mice were fed normal a control (NC), high fat (HF) or high glycaemic index (HGI) diet and infected 
once monthly with 500 L3 from Nippostrongylus brasiliensis. (A) Bacterial order abundance between normal 
control naïve (N) and normal control N. brasiliensis (Nb) infected groups; (B) Bacterial order abundance 
between high fat naïve (N) and high fat N. brasiliensis (Nb) infected groups; (C) Bacterial order abundance 
between high glycaemic index naïve (N) and high glycaemic index N. brasiliensis (Nb) infected groups. P 
value based on ANOVA-like differential expression analysis. The data are representative of two different 
























































































4.4.3. Treatment with N. brasiliensis L3ES and AES resulted in alternation in the microbial 
profile of both normal control diet and high glycaemic index diet groups 
In order to address the effect of treatment with L3ES or AES of N. brasiliensis on the 
composition of gut microbiota in the HGI model of diet-induced T2D, 5 week old male C57BL/6 
mice were fed either a NC or HGI diet to induce T2D. Treatment with N. brasiliensis L3ES or AES 
started at week 6 and continued twice every week until the end of the experiment. Stool samples were 
collected at the end of the experiment to determine the differences in the composition of gut 
microbiota. RDA on an OTU level was significantly different in both NC diet and HGI diet groups 
treated with L3ES or AES compared to their untreated littermates (Fig. 4.4.4A; Fig. 4.4.5A). Adonis 
analysis, showed significant differences in the L3ES treated groups on both diets compared to their 
untreated naïve groups based on Bray-Curtis and spearman index (Table 1).  The AES treated group 
fed a HGI diet but not on the NC diet showed significant differences measured by an Adonis test 
based on Bray-Curtis and spearman index (Table 1). The α-diversity and the richness increased 
significantly in the HGI diet group treated with L3ES compared to their untreated naïve group 
(Supplementary Fig. S2). However, the α-diversity and the richness were not statistically significant 
in any of the HGI diet groups treated with AES or the NC diet group treated with AES and L3ES 






































4.4.5. Treatment with L3ES or AES of N. brasiliensis alters the abundance of bacterial taxa  
L3ES or AES treatment showed no significant changes in the most dominant phyla in 
comparison with their untreated littermates in both diets (Fig. 4.4.5). There was only a significant 
increase in the abundance of the Verrucomicrobia phylum of the NC diet group treated with L3ES 
compared to the naïve un-treated group. No differences in any other phyla were detected (Fig. 
4.4.5A). The abundance of the Actinobacteria phylum showed a significant decrease in the HGI diet 
groups treated with either L3ES or AES compared to their untreated littermates. Furthermore, the 
abundance of the Patescibacteria phylum significantly increased in the AES group fed on a HGI diet 
(Fig. 4.4.5B). At the order level, the Coriobacteriales group belonging to Actinobacteria showed a 
significant decrease in abundance in the NC and HGI diet groups treated with L3ES, as well as in the 
HGI diet group treated with AES (Fig. 4.4.6A and 4.4.6B). Verrucomicrobiales belonging to 
Verrucomicrobia significantly increased in the NC and HGI diet groups treated with L3ES or AES, 
respectively. However, this order showed a significant decrease in abundance in the HGI diet group 
treated with L3ES (Fig. 4.4.6A and 4.4.6B). Desulfovibrionales, Rhodospirillales and 
Betaproteobacteriales belonging to the Proteobacteria phylum showed a significant decrease in the 
NC diet group treated with L3ES, the NC diet group treated with AES and the HGI diet group treated 
with L3ES, respectively, compared to naïve littermates (Fig. 4.4.6A and 4.4.6B). The abundance of 
Saccharimonadales belonging to the Patescibacteria phylum and Lactobacillales belonging to the 
Firmicutes phylum were significantly higher in the HGI group treated with AES compare to their 






Fig 4.4.4. Treatment with L3ES or AES of N. brasiliensis resulted in alternation in the 
microbial profile of both normal control diet and high glycaemic index diet groups. 
C57/BL6 mice were fed normal control (NC) or high glycaemic index (HGI) diets and treated twice weekly 
with L3ES or AES of Nippostrongylus brasiliensis (A) Multivariate redundancy analysis between normal 
control naïve (N) and normal control N. brasiliensis (L3ES) or (AES) treated groups (B) Multivariate 
redundancy analysis between high glycaemic naïve (N) and high glycaemic N. brasiliensis (L3ES) or (AES) 




























Fig 4.4.5. Treatment with L3ES or AES of N. brasiliensis alters the abundance of bacterial 
phyla. 
C57/BL6 mice were fed normal control (NC) or high glycaemic index (HGI) diets and treated twice weekly 
with L3ES or AES from Nippostrongylus brasiliensis. (A) Quantitative visualisation of phylum abundance 
between normal control naïve (N) and normal control N. brasiliensis (L3ES) or (AES) treated groups; (B) 
Quantitative visualisation of phylum abundance between high glycaemic index naïve (N) and high glycaemic 
index N. brasiliensis (L3ES) or (AES) treated groups. P value based on ANOVA-like differential expression 












































Fig 4.4.6. Treatment with L3ES or AES of N. brasiliensis alters the abundance of bacterial 
order. 
C57/BL6 mice were fed normal control (NC) or high glycaemic index (HGI) diets and treated twice weekly 
with L3ES or AES from Nippostrongylus brasiliensis. (A) Bacterial order abundance between normal control 
naïve (N) and normal control N. brasiliensis (L3ES) or (AES) treated groups; (B) Bacterial order abundance 
between high glycaemic index naïve (N) and high glycaemic index N. brasiliensis (L3ES) or (AES) treated 
groups. P value based on ANOVA-like differential expression analysis. The data are representative of one 

































































































































4.5 Discussion  
Changes in environmental factors such as diet can modulate bacterial composition and 
metabolic activity (332). These changes can result in a higher intestinal glucose and energy absorption 
as well as an increase in the absorption of LPS produced by gut microbiota, which can trigger an 
inflammatory immune response leading to the development of T2D (275, 332). Indeed, there is 
growing evidence that helminth infection and their ES products alter the composition of the gut 
microbial community, conferring protection against immune mediated diseases such as allergic 
inflammation (250), CD (251), obesity (254, 255), arthritis (256, 352) and Lupus (341). Here, firstly 
we aimed to address the effect of infection with N. brasiliensis on the composition of the gut 
microbiota in mice fed with a normal control diet and in two mouse models of diet induced T2D (HF 
and HGI). Secondly, we aimed to address the effect of treatment with N. brasiliensis L3ES or AES 
on the composition of the gut microbiota in mice fed a normal control diet or a HGI diet that caused 
the development of T2D.  
No significant changes were observed in α-diversity in response to N. brasiliensis infection 
in all diets studied (NC, HF and HGI diet); however, we still found a significant shift in the microbiota 
composition at the community level. This was in agreement with other studies with N. brasiliensis 
and Hymenolepis diminuta that also found no significant differences in α-diversity between infected 
and uninfected groups (246, 253), which suggested inter-individual variation in the microbiota 
composition as a result of infection (246). In the latter study, mice on a NC diet infected with N. 
brasiliensis showed a significant reduction in the Firmicutes phylum and an increase in 
Bacteroidetes/S24-7 and Actinobacteria/Coriobacteriaceae. However, in our study we found that, in 
response to infection, the NC group had non-significant increases in both Firmicutes and 
Bacteroidetes phyla, while Actinobacteria (in particular the Bifidobacteriales group) abundance was 
significantly lower and abundance of order Clostridiales belonging to Firmicutes phylum was 
Groups p-value Bray-Curtis p-value spearman index
NCN vs NCNb 0.002 0.0003
HFN vs HFNb 0.0006 0.005
HGIN vs HGINb 0.06 0.03
NCN vs NCL3ES 0.01 0.004
NCN vs NCAES 0.14 0.1
HGIN vs HGIL3ES 0.0003 0.0003
HGIN vs HGIAES 0.0006 0.0003
Table:1 Adonis p-value result based on Bray-Curtis and spearman index
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significantly higher. While the aforementioned study found that among the Firmicutes phylum 
abundance of Clostridiaceae, Peptostreptococcaceae and Turicibacteraceae were significantly 
lower, abundance of the Lactobacillaceae was significantly higher in the infected group (246). The 
differences between this study and our own study reported herein might be a result of the differences 
in the microbiota analysis in terms of 16srRNA amplification and sequencing, as well as differences 
in the experimental design in terms of infection strategy and time point for both experiments, as 
studies in humans (353, 354) and mice (355) found changes in the composition of gut microbiota 
correlating with age. In agreement with our findings, in human studies, individuals with different 
helminth infections (i.e. Trichuris spp., Ascaris spp. and hookworm) had lower abundance of the 
Bifidobacteriales compared to helminth uninfected individuals (261). Many linked the latter group 
with health benefits in T2D (356); however, others have reported them as causing infections (357). 
In mouse studies, infection with T. muris or H. polygyrus protected against CD in NOD2-/- deficient 
mice (251) and attenuated allergic airway inflammation in mice inoculated with HDM (250), which 
was associated with an increase in the abundance of the order Clostridiales (250, 251). 
In regard to diabetic groups, infection increased the abundance of the Clostridiales group in 
the HF diet group as well as the abundance of Desulfovibrionales and Burkholderiales belonging to 
Proteobacteria in the HF and HGI diet groups, respectively. As previously mentioned, in a mouse 
study, attenuation of allergic airway inflammation was associated with an increase in the abundance 
of Clostridiales (250). It has also been reported that reduction in the abundance of Clostridia was 
associated with T2D in humans (236, 339, 340, 358), and an increase in this group was associated 
with an improvement in glucose and lipid metabolism (359). In one study, the Proteobacteria phylum 
also increased in H. polygyrus-infected mice fed a NC or a HF diet compared to naïve littermates. 
This phylum is, in part, responsible for regulating weight gain in HF diet fed mice (254). Abundance 
of Desulfovibrionales order, class and family were increased in mouse faecal samples as a result of 
infection with Schistosoma heamatobium (360), Ascaris lumbricoides and Trichuris trichiura (361). 
Moreover, the abundance of Desulfovibrionales and Burkholderiales groups was lower in obese mice 
(362). Cold exposure attenuated diet-induced obesity in mice, which was associated with an increase 
in the abundance of Desulfovibrionaceae (363). Diabetic rats treated with insulin had higher relative 
abundance of Burkholderiales; however, another study found lower abundance of the 
Desulfovibrionales order in diabetic rats when treated with insulin (364). Others have also reported 
an increase in the abundance of the Desulfovibrionales order and family in HF compared to NC diet 
fed groups (365, 366). Desulfovibrionales are sulphate-reducing bacteria that use hydrogen or other 
compounds such as lactate, pyruvate and ethanol as electron donors to produce hydrogen sulphide 
(H2S) (367), which is implicated in intestinal disease (368). So, on both sides, many parameters need 
to be considered, such as the concentration of sulphide inside the intestine and the ability of IECs to 
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detoxify and to utilise sulphide as an energy source and other mechanisms that might be involved in 
the signalling pathway of H2S (368). In our study, the Verrucomicrobiales group belonging to the 
Verrucomicrobia phylum and the CW040 group belonging to the TM7 phylum were significantly 
lower in the HGI group infected with N. brasiliensis in comparison with uninfected littermates . 
Verrucomicrobia and TM7 groups were significantly higher in obese compared to non-obese children 
(369), and mice with leptin deficiency (db/db)-induced T2D showed an increase in the abundance of 
Verrucomicrobia (370). However, these mice exhibited a decrease in the abundance of 
Verrucomicrobia when subjected to an intermittent fasting regime which protected against diabetic 
retinopathy (371).  
In regard to treatment with N. brasiliensis ES products, while mice on a NC diet treated with 
AES or L3ES and those on a HGI diet treated with AES showed non-significant increases in α-
diversity based on Shannon index, those on a HGI diet treated with L3ES had significantly higher α-
diversity. The NC diet group treated with L3ES as well as the HGI diet groups treated with L3ES or 
AES had lower abundance of the Actinobacteria/Coriobacteriales group compared to the untreated 
controls. The abundance of members of the Coriobacteriaceae family was increased in obese children 
and adolescents compare to their normal weight groups (372). Patients with T2D had increased 
abundance of Coriobacteriales in comparison with the non-diabetic and pre-diabetic groups (373). 
Moreover, T2D patients with cardiovascular complications had higher abundance of  the latter group 
compare to the diabetic patients without cardiovascular complications (374). Rats fed a fructose-rich 
diet had higher Coriobacteriales/Coriobacteriaceae compared to rats fed a control diet (375), however 
faecal microbiota transplantation from the latter control group to the high fructose diet group resulted 
in decreased Coriobacteriaceae abundance (375). In our study, the Verrucomicrobia/ 
Verrucomicrobiales group showed a different outcome, as NC diet mice treated with L3ES and HGI 
diet mice treated with AES had a higher abundance of this group, however those mice on a HGI diet 
treated with L3ES had lower abundance of Verrucomicrobiales than their control groups. In one 
study, mice treated with helminth derivative phosphorylcholine TPC had lower abundance of 
Verrucomicrobia but higher abundance of Clostridiaceae compared to their control group (341). 
Furthermore, as we mentioned previously, in obese people (369) as well as in obese mice, (370) 
researchers reported an increase in the abundance of the Verrucomicrobia group. However, another 
study found a decrease in the abundance of Verrucomicrobia in both prediabetes and T2D subjects 
(376). Verrucomicrobia are mucin degrading bacteria (377) implicated in health and disease. In this 
sense, systematic contribution of mucin degrading bacteria in gut homeostasis and dysbiosis has yet 
to be investigated (378). 
Abundance of Desulfovibrionales, Betaproteobacteriales and Rhodospirillales groups 
belonging to proteobacteria was lower in NC diet group treated with L3ES, HGI diet group treated 
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with L3ES and NC diet group treated with AES respectively compare to their untreated littermates. 
In a previous study, mice fed with a diet that was rich in fat, fructose and cholesterol had a higher 
abundance of Rhodospirillales compared to the control diet fed group (379). Moreover, pre-diabetic 
and diabetic subjects had a higher abundance of Betaproteobacteria compared to non-diabetic subjects 
(236, 376).  
Abundance of Saccharimonadales (belonging to Patescibacteria) and Lactobacillales groups 
was significantly higher in the HGI diet group treated with AES compare to their untreated group. 
Patescibacteria are anaerobic fermenters, but this newly identified bacterial group has not been well 
studied and information on their function is still scarce (380). Lactobacillus on the other hand has 
been widely studied, and different Lactobacillus probiotic strains have been reported to improve 
parameters related to T2D (381). 
Many factors may play a role in modulating the abundance of microbial species in the gut. 
The bacterial composition can vary in the same individual due to variation in the physiology, pH and 
O2 tension, digesta flow rates in different anatomical regions, as well as between individuals due to 
variation in genetic factors, environment and habitual dietary intake (382). These variations can be 
factors contributing to the onset of many diseases and may have potential therapeutic implications 
(383). Correlation between helminth presence and changes in the microbial composition have already 
been mentioned elsewhere throughout, but it is pertinent to note that many studies reported changes 
in the composition of the gut microbiota as a result of helminth infection and subsequent improvement 
in the outcome of immune mediated diseases. Whether the changes we found in our study are a direct 
effect of helminth infection or a consequence of the host’s immune response to the infection, and 
whether these changes are essential to confer protection against T2D are yet to be investigated. A 
deeper understanding of the interplay between the host-microbiota-helminth triad and other variables 















































Supplementary Fig 4.4.1: Infection with N. brasiliensis resulted in altered alpha diversity 
and microbial richness in normal control and T2D mice. 
C57/BL6 mice were fed either a normal control (NC), high fat (HF) or high glycaemic index (HGI) 
diet and infected once monthly with 500 Nippostrongylus brasiliensis L3. Microbial alpha 
diversity and richness in the small intestine of N. brasiliensis infected groups (Nb) and uninfected 
groups (N) in normal control diet (NC) diet, high fat (HF) diet and high glycaemic index (HGI) 















































Supplementary Fig 4.4.3: Treatment with N. brasiliensis L3ES and AES resulted in alternation 
in the alpha diversity and species richness of both normal control diet and high glycaemic index 
diet groups. 
C57/BL6 mice were fed normal control (NC) or high glycaemic index (HGI) diets and treated twice 
weekly with L3ES or AES of Nippostrongylus brasiliensis. Microbial alpha diversity and richness in 
the faecal samples of N. brasiliensis (L3ES) and (AES) treated groups and untreated groups (N). (A) 
In normal control diet (NC). (B) In high glycemic index diet (HGI). The data are representative of 
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5. General Discussion 
 
5.1 Overview 
DM is widely distributed and considered the fourth leading cause of non-communicable disease 
deaths. DM and the associated pathologic sequelae are responsible for about 5.1 million deaths per 
year globally and accounted for USD 727 billion of the world’s health expenditure in 2017 (3). It has 
been reported that the prevalence of diabetes is higher in urban (279.2 million) than in rural (145.7 
million) areas and this gap is predicted to widen to 472.6 million people in urban areas and 156 
million in rural areas by 2045, with wide variations in this prevalence worldwide (3). For example, 
the Western Pacific region has the highest number of people with diabetes (159 million people), 
followed by South-East Asia (82 million), Europe (58 million), and North America (46 million) (3). 
Further, it has been shown that T2D occurs in youth, with the highest rates observed in people aged 
15–19 (384). Moreover, it has been estimated that 352.1 million people have impaired glucose 
tolerance worldwide and nearly half of those are under the age of 50 (3). T2D is characterised by a 
persistent elevation in the blood glucose level due to an absolute or relative deficiency in insulin or 
resistance to its action (385).  
Diabetes is a multifaceted disease where genetics, immunological factors and environmental 
factors have a major role in its pathogenesis (386). Appropriate balance between pro-inflammatory 
and anti-inflammatory immune responses is essential to maintain whole body homeostasis and to 
avoid inflammatory diseases (387). Inflammation is a crucial factor contributing to the development 
of T2D (388). In T2D, levels of certain inflammatory molecules are increased, and the components 
of the immune system are skewed toward pro-inflammatory subsets (388). It has been proposed that 
changed dietary habits, a cleaner environment, vaccination programmes and excessive antibiotic use 
have reduced our exposure to many infectious agents and symbiotic microorganisms (including 
helminths and gut microbiota) that had an evolutionary relationship with humans, and this 
relationship helps in the regulation of immune responses and preservation of homeostasis (389). It 
has been suggested that gut microbiota composition has an effect on the pathogenesis of T2D (390). 
Lack of exposure to pathogens is thought to increase susceptibility to allergic and autoimmune 
diseases like, asthma, IBD and T1D (65). Epidemiological studies as well as experimental studies 
have reported an inverse relationship between the presence of helminths and T2D (391). Moreover, 
helminth presence has been linked with microbiota diversity and composition which may contribute 
to beneficial health effects in the host (392). Hence, alteration of the gut microbiome in the presence 
of helminth parasites might contribute to improved metabolic outcomes observed in T2D. 
84	
	
Data presented in this dissertation provide evidence that infection with N. brasiliensis and 
administration of its ES products from both adult larval stages significantly decreased blood glucose 
levels and reduced body weight gain in mice using two different models of diet-induced T2D: HGI, 
HF. Specifically, I have shown that N. brasiliensis infection and administration of ES products 
resulted in significantly increased systemic eosinophil responses in different organs including MLNs, 
AT, and liver. This was associated with an increase in type 2 immune responses measured by IL-4, 
Chil3 and Rentla in AT, liver and gut tissue and an increase in the levels of IL-4 and IL-5 in AT and 
liver of ES treated groups. I also found that infection with N. brasiliensis or treatment with their ES 
products showed a significant difference in the microbial profile of those groups compared to naïve 
littermates. Moreover, there were trends towards an increase in the gut microbial diversity and 
changes in specific bacterial taxa after helminth infection or treatment with ES products. 
5.1.1 N. brasiliensis infection and ES products improve glucose metabolism and regulate the 
immune responses associated with T2D. 
Helminth infections play a crucial role in the induction of Th2- and Treg-mediated immune 
responses in many inflammatory disorders such as IBD, MS, arthritis, asthma and T1D (270). 
Similarly, it has been reported that helminth infections showed promising results in patients with 
IBD, celiac disease and MS (104, 105, 271). Further, it has been demonstrated that helminths and 
their secretions can regulate the host’s immune response, which might have beneficial effects in 
promoting or preventing the inflammatory responses associated with immune-mediated diseases 
(164). 
In our studies, we found that infection with N. brasiliensis or treatment with its ES products 
had a beneficial effect against T2D in two different diabetic models. Infection with N. brasiliensis or 
treatment with their ES products significantly induced peripheral glucose uptake and specific glucose 
sensitivity and reduced body weight gain (see results from Chapter 2 & 3). In line with my studies, 
infection with N. brasiliensis decreased weight gain and improved glucose metabolism in two 
different models of obese mice, which was associated with induction of Th2 immune responses (136). 
Other studies have also reported improvements in glucose tolerance of obese mice after infection with 
the filarial helminth L. sigmodontis or administration of soluble adult worm extract which was 
associated with an increase in the numbers of CD4+ T cells, eosinophils and AAMs in the AT. 
Depletion of eosinophils resulted in impaired glucose tolerance (137). Infection with H. polygyrus 
also resulted in decreased body weight gain and improved glucose and lipid metabolism with 
increases in Th2/Treg immune responses in the MLNs, AT, liver and gut. (134, 135). SEA from S. 
japonicum decreased the level of blood sugar and induced Th2 and Treg immune responses that 
protected against T2D in mice (315).  
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5.1.2 Mechanism(s) by which N. brasiliensis and their ES regulate immune responses to T2D. 
In the present study I have identified an important role for helminth infection in the induction 
of type 2 immune responses by enhancing eosinophil recruitment in MLNs, AT and liver, with 
increased expression of IL-4 and markers of M2 MACs Rentla and Chil3 in AT, liver and SI (see 
results from Chapter 2). Further, I showed that administration of N. brasiliensis crude ES from adult 
and L3 stages also induced eosinophil recruitment in the MLNs, AT and liver, with a significant 
increase in the level of IL-5 in the AT and liver (see results from Chapter 3). In line with my results, 
N. brasiliensis infectyion resulted in improved insulin sensitivity and lipid metabolism, decrease in 
adiposity and increase in energy expenditure in mouse models of obesity (37, 41, 136). Infection with 
N. brasiliensis is associated with induction of Th2 immune responses, resulting in the production of 
IL‐4, IL‐5, IL‐9, IL‐10, IL‐13, IL-25 and IL-33 and induction of a systemic and localized eosinophilia, 
ILC2s and M2 MACs (94, 280-285, 393-395). Infection with N. brasiliensis induces residential 
ILC2s that secret and maintain IL-5 leading to local eosinophil accumulation (396). Also, N. 
brasiliensis induced ILC2s and CD+4 T cells and expansion of IL-4 and/or IL-13 that maintain M2 
MACs (280). N. brasiliensis infection drives signaling via IL-4/IL-13/STAT-6 axis (282, 284), which 
has already been reported to be involved in the regulation of lipid metabolism leading to weight loss 
in obese mice after N. brasiliensis infection (136). 
Eosinophils are involved in the regulation of homeostasis of many tissues including 
gastrointestinal tract, lungs, adipose tissue, thymus, uterus and mammary glands (397). Recently, 
eosinophils have been implicated in the regulation of glucose metabolism and energy expenditure 
(37, 41, 288, 298, 398). IL-5 promotes eosinophil development, activation and survival (397). IL-5 
plays an important role in promoting AT eosinophils that maintain adipose AAMs. Eosinophil 
accumulation in AT was impaired in IL-5 deficient mice, leading to increased body fat, impaired 
glucose tolerance and insulin resistance in obese mice (37, 41). An in vitro study found that IL-4 
restored insulin sensitivity in an experimental IR model of 3T3-L1 adipocytes (293). Moreover, IL-4 
decreased blood glucose and body weight, which promotes insulin sensitivity and inhibits 
accumulation of lipids in AT and reduced the adipocyte layer in the skin in vivo (292, 295). Emerging 
studies implicate different immunological pathways in the regulation of glucose metabolism and 
energy expenditure. Resident ILC2s in AT increase production of IL-5 and IL-13, which promotes 
accumulation of eosinophils and M2 MACs. This reduces inflammation in AT and increases insulin 
sensitivity and beiging of AT (41, 399). Another study has highlighted the role of Metrnl in the 
recruitment of eosinophils to the AT (398). This induced IL4/IL13, which are required to increase 
M2 MAC numbers and induction of AT beiging (298, 398). Moreover, the IL-33/ILC2 axis can 
promote beiging in AT and limit adiposity via increasing caloric expenditure that regulates metabolic 
homeostasis (290). Signaling via IL-4/ STAT6 regulates nutrient metabolism in the liver and insulin 
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sensitivity and attenuates body weight and AT inflammation (291). Considering these multiple 
immunological signaling pathways, a plausible mechanism by which N. brasiliensis improves 
glucose metabolism and decreases adiposity might due to local and systemic eosinophilia that leads 
to expansion of Th2 cytokines and M2 MACs.  
Regarding treatment with N. brasiliensis ES products, I have reported that administration of 
AES or L3ES twice weekly at a dose of 1 mg/kg resulted in significantly decreased blood glucose 
levels and attenuation of body weight gain. This was associated with an increase in the level of AT 
and liver IL-5 and a trend towards an increase in the level of IL-4 in these tissues. Expression of IL-
6 significantly decreased in AT but increased in the liver. As previously discussed, eosinophils play 
a role in the increase in levels of IL-5 and/or IL-4 in regulating glucose and lipid metabolism as well 
as energy expenditure (37, 41, 399). An in vitro study revealed that treatment of intestinal pig 
epithelial cells with T. suis ES products resulted in increased levels of IL-6 and IL-10, with no 
secretion of IL-4 in both differentiated and undifferentiated cells (323). Although an increase in the 
levels of IL-6 were reported to be involved in the induction of insulin resistance in the AT and liver 
and pathogenesis of T2D (324, 325), others have reported a beneficial role for IL-6 in liver 
regeneration and maintenance of liver tissue homeostasis as well as protection against liver 
inflammation and insulin resistance (326-328). Human PBMC stimulated with a-CD3 and a-CD28 
antibodies showed up-regulation in the expression of IL-4 and IL-5 after short term preincubation 
with IL-6. However, long term preincubation of these cells with IL-6 led to gradual disappearance of 
its effect on IL-4 production but the effect on IL-5 became more pronounced (329). Moreover, IL-6 
enhanced in vivo and in vitro expansion and survival of Ag-stimulated CD4+ T cells in the blood, 
lymph nodes, spleen, liver and lung, which reduced the level of apoptosis in these cells (330). 
Furthermore, splenocytes of TLR2+/+ mice immunised with OVA in the presence of eosinophil-
derived neurotoxin (EDN) produced IL-5, IL-6, IL-10 and IL-13, whereas in the presence of LPS 
they produced IFN-γ (331). So, it is more likely that the increase in the levels of IL-6 in the liver that 
I observed are a consequence of avoiding apoptosis in this tissue, and which might be mediated via 
EDN activating TLR2 and expansion and survival of CD4+ T cells in the liver. The mechanisms by 
which IL-6 might enhance a protective effect against T2D has yet to be investigated. 
5.1.3 Mechanism(s) by which N. brasiliensis and host microbiota regulate immune responses and 
T2D. 
The gut microbiota that inhabits the mammalian body plays an essential role in regulating 
host metabolism, physiology, nutrition and immune function (400). Changes in environmental factors 
such as dietary habits, excessive use of antibiotics, sanitation, mode of birth and feeding pattern all 
can have a devastating impact on the composition and diversity of the intestinal microbiota (401). 
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Changes in the composition of the gut microbiota as a result of helminth infections have been reported 
by many researchers (244-247, 249, 257, 261). On the other hand, a growing body of evidence 
suggests that helminth infections and their ES products can alter the gut microbial community, 
leading to protection against immune mediated diseases, such as allergic inflammation, colitis, 
obesity, arthritis and lupus (250, 251, 254-256, 341, 352). 
My data showed significant differences in the clustering analysis between N. brasiliensis 
infected groups compared to naïve groups in all diets (NC, HGI and HF diets). The same result was 
found between the groups treated with L3ES or AES and untreated littermates in both NC and HGI 
diets. However, no significant differences in α-diversity and richness were detected in the N. 
brasiliensis infected groups compared to the uninfected groups, as well as between L3ES or AES 
treated groups on a NC diet, or the AES treated group on a HGI diet compared to the untreated groups. 
Only mice on a HGI diet and treated with L3ES showed significantly higher α-diversity and richness 
when compared with the naïve group; however, I still found significant changes in the community 
composition at the phylum and order levels in the infected as well as treated groups compared to 
naïve littermates, but each of them showed variability among different diets as well as between the 
different treatments (L3ES and AES). Clostridiales increased while Bifidobacteriales decreased in 
the NC diet group. Clostridiales and Desulfovibrionales increased in the HF diet group. 
Burkholderiales increased, while CW040 and Verrucomicrobiales decreased in the HGI diet group. 
Coriobacteriales and Desulfovibrionales decreased, while Verrucomicrobiales increased in the NC 
diet group treated with L3ES. Rhodospirillales decreased in the NC diet group treated with AES. 
Coriobacteriales, Verrucomicrobiales and Betaproteobacteriales decreased in the HGI group treated 
with L3ES. Coriobacteriales decreased while Verrucomicrobiales, Saccharimonadales and 
Lactobacillales increased in the HGI diet group treated with AES.  
It has been reported that T2D patients had lower abundance of Clostridiales and this group 
negatively correlated with glucose and lipid metabolism (236, 339, 340, 358, 359). Moreover, the 
microbiota of diabetic group is represented in lower members of Bifidobacterium in comparison with 
the healthy group (402). These organisms are reported to be associated with health benefits in T2D 
(356); however, a few studies have reported Bifidobacterium to cause infections (357). The 
Burkholderiales group was lower in obese mice, and treatment of diabetic rats with insulin increased 
the abundance of Burkholderiales (362, 364). I found a conflicting result regarding 
Desulfovibrionales and Verrucomicrobiales, although this controversy is also found in the literature. 
While some groups have reported a decrease, others have reported an increase in the abundance of 
the Desulfovibrionales group when treating obese and diabetic rats with insulin (362, 364, 365). 
Furthermore, while some researchers reported an increase in the abundance of the Verrucomicrobia 
group in obesity and T2D, others found a decrease in the abundance of this group (369-371, 376). In 
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addition, order CW040 belongs to the TM7 phylum, and this phylum has been found to be higher in 
obese children and adolescents (369). A fat, fructose and cholesterol-rich diet has been associated 
with a higher abundance of Rhodospirillales (379). Also, a higher abundance of Betaproteobacteriales 
has been detected in pre-diabetic and diabetic subjects (236, 376). Saccharimonadales belonging to 
the Patescibacteria phylum are anaerobic fermenters and a newly identified bacterial group from 
which little is known (380). The effect of many different Lactobacillus probiotic strains has been 
reported in their ability to improve parameters related to T2D (381). My result are in line with other 
studies conducted in humans and rats that found no changes in α-diversity as a result of infection with 
different parasitic nematodes, but still reported some changes in the bacterial communities (253, 403, 
404). To explain the variability in the microbiota community composition among different diets as a 
result of infection as well as between the different treatments, one might consider the differences in 
the dietary substrates. We also should consider the pathways for the metabolism of these substrates 
as well as the inter-individual variation in the metabolism they can have and its implication on the 
abundance of different microbial species in the gut (405). In my work, the sample size was small, 
which allowed greater sampling variability. On the other hand, helminth presence has diverse effects 
on the composition of the gut microbiota, with some species having minor effects while others have 
greater effect swith potential to protect against immune-mediated diseases. In summary, infection 
with N. brasiliensis or treatment with their ES products has no effect on microbial a-diversity; 
however, clustering analysis demonstrates the existence of discrete bacterial communities. Many 
factors can influence the abundance of microbial species in the gut, such as diet, host physiology and 
inflammatory immune responses produced as a consequence of helminth invasion; however, whether 
the changes I found in this study are a cause of direct and/or indirect effect of helminth infection or 
their ES products or a consequence of host immune response, and whether these changes are essential 
to confer protection against T2D are yet to be investigated. 
 
5.2 Conclusion 
In conclusion, in this thesis I found that infection with N. brasiliensis or treatment with AES 
or L3ES improves glucose metabolism and decreases body weight gain in diet-induced T2D mouse 
models. This was associated with an increase in systemic and peripheral eosinophilia along with an 
increase in Th2 immune responses, characterised by an increase in IL-4, Rentla and Chil3 in infected 
groups and an increase in IL-5 and a trend towards an increase in IL-4 with a decrease in IL-6 in AT 
but not in liver of AES and L3ES treated groups. I found no changes in a-diversity after infection or 




5.3 Future perspective 
• In my work I demonstrated a role for eosinophils in the improvement of glucose metabolism 
and modulating the immune response associated with T2D. Further studies in eosinophil-
depleted mice would be important to elucidate if this pathway is important for the beneficial 
effect. 
• I reported an involvement of other immune cells including M2 MACs, ILC2s and Tregs, so 
these cell types and their roles in protecting against T2D need to be addressed. 
• A large-scale study is important to address the role of infection or treatment with ES on the 
gut microbiota composition. Also, a microbiota depletion study will also be important to 
address whether the gut microbiota is essential for protection against T2D after helminth 
infection or treatment with ES products.   
• Further work should be aimed at addressing the potential of anti-inflammatory proteins 
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